


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:50:02Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12407878" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12407878</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>viru</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Virulence</journal-id><journal-id journal-id-type="iso-abbrev">Virulence</journal-id><journal-id journal-id-type="pmc-domain-id">1371</journal-id><journal-id journal-id-type="pmc-domain">viru</journal-id><journal-title-group><journal-title>Virulence</journal-title></journal-title-group><issn pub-type="ppub">2150-5594</issn><issn pub-type="epub">2150-5608</issn><publisher><publisher-name>Taylor &amp; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12407878</article-id><article-id pub-id-type="pmcid-ver">PMC12407878.1</article-id><article-id pub-id-type="pmcaid">12407878</article-id><article-id pub-id-type="pmcaiid">12407878</article-id><article-id pub-id-type="pmid">40888366</article-id><article-id pub-id-type="doi">10.1080/21505594.2025.2551176</article-id><article-id pub-id-type="publisher-id">2551176</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" vocab-term="Version of Record" article-version-type="VoR">Version of Record</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Bacterial Pathogenesis</subject></subj-group></article-categories><title-group><article-title>Autophagy-driven modulation of stem cell dynamics in <italic toggle="yes">Helicobacter pylori</italic>-induced gastric diseases in mice</article-title><alt-title alt-title-type="left-running-head">J. LI ET AL.</alt-title><alt-title alt-title-type="right-running-head">VIRULENCE</alt-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="J">Jing</given-names></name><xref rid="aff0001" ref-type="aff"/><xref rid="an0003" ref-type="author-notes">
<sup>*</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/" vocab-term="Data curation">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/" vocab-term="Investigation">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/" vocab-term="Writing &#x2013; original draft">Writing &#8211; original draft</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="S">Sisi</given-names></name><xref rid="aff0001" ref-type="aff"/><xref rid="an0003" ref-type="author-notes">
<sup>*</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/" vocab-term="Data curation">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/" vocab-term="Investigation">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/" vocab-term="Writing &#x2013; original draft">Writing &#8211; original draft</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="Z">Zhiqin</given-names></name><xref rid="aff0001" ref-type="aff"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/" vocab-term="Formal analysis">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/" vocab-term="Investigation">Investigation</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ma</surname><given-names initials="C">Chunlei</given-names></name><xref rid="aff0001" ref-type="aff"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/" vocab-term="Formal analysis">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/" vocab-term="Investigation">Investigation</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="B">Boqing</given-names></name><xref rid="aff0001" ref-type="aff"/><xref rid="an0002" ref-type="corresp"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/" vocab-term="Data curation">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/" vocab-term="Project administration">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/" vocab-term="Writing &#x2013; review &amp; editing">Writing &#8211; review &amp; editing</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cui</surname><given-names initials="Y">Yingzi</given-names></name><xref rid="aff0001" ref-type="aff"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/" vocab-term="Methodology">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/" vocab-term="Software">Software</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="W">Wenke</given-names></name><xref rid="aff0001" ref-type="aff"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/" vocab-term="Data curation">Data curation</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0006-4449-354X</contrib-id><name name-style="western"><surname>Zhao</surname><given-names initials="H">Huilin</given-names></name><xref rid="aff0001" ref-type="aff"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/" vocab-term="Data curation">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/" vocab-term="Formal analysis">Formal analysis</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ji</surname><given-names initials="X">Xiaofei</given-names></name><xref rid="aff0001" ref-type="aff"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/" vocab-term="Data curation">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/" vocab-term="Formal analysis">Formal analysis</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4452-2359</contrib-id><name name-style="western"><surname>Zhang</surname><given-names initials="Y">Ying</given-names></name><xref rid="aff0001" ref-type="aff"/><xref rid="an0001" ref-type="corresp"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/" vocab-term="Funding acquisition">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/" vocab-term="Investigation">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/" vocab-term="Project administration">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/" vocab-term="Writing &#x2013; review &amp; editing">Writing &#8211; review &amp; editing</role></contrib><aff id="aff0001">School of Basic Medical Sciences, <institution-wrap><institution>Binzhou Medical University</institution></institution-wrap>, <city>Yantai</city>, <country>China</country></aff></contrib-group><author-notes><corresp id="an0001">CONTACT Ying Zhang <email xlink:href="mailto:zhangying@bzmc.edu.cn">zhangying@bzmc.edu.cn</email></corresp><corresp id="an0002">Boqing Li <email xlink:href="mailto:liboqing@bzmc.edu.cn">liboqing@bzmc.edu.cn</email></corresp><fn id="an0003"><label>*</label><p>These authors contributed equally to the paper.</p></fn></author-notes><pub-date date-type="pub" publication-format="electronic"><day>1</day><month>9</month><year>2025</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2025</year></pub-date><volume>16</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">478704</issue-id><elocation-id seq="207">2551176</elocation-id><pub-history><event event-type="pmc-release"><date><day>01</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 16:25:19.050"><day>04</day><month>09</month><year>2025</year></date></event><event event-type="tagger"><event-desc>Integra</event-desc><date><day>29</day><month>8</month><year>2025</year></date></event><event event-type="final"><event-desc>Integra</event-desc><date><day>29</day><month>8</month><year>2025</year></date></event><event event-type="received"><date><day>27</day><month>1</month><year>2025</year></date></event><event event-type="revised"><date><day>16</day><month>7</month><year>2025</year></date></event><event event-type="accepted"><date><day>14</day><month>8</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="KVIR_16_2551176.pdf"/><self-uri content-type="pdf" xlink:href="KVIR_16_2551176.pdf"/><abstract><title>ABSTRACT</title><p>Chronic <italic toggle="yes">Helicobacter pylori</italic> infection is a major contributor to gastric disease progression, with its involvement in autophagy and stem cell dynamics playing a critical role in disease mechanisms. This study investigated how <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>, particularly in combination with the carcinogen N-nitroso-N-methylurea (NMU), disrupted autophagy and stem cell function, driving gastric pathology. <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> infection significantly increased autophagy, promoted the epithelial&#8211;mesenchymal transition, suppressed <italic toggle="yes">Tff2</italic> and <italic toggle="yes">Ghrelin</italic> expression in mouse gastric organoids, and enhanced stem cell proliferation (organoid numbers increased 92% compared to control at 24&#8201;weeks, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001), while NMU caused milder autophagy, severe inflammation, glandular dilation, and reduced stemness markers (CD133 decreased 30% at 24&#8201;weeks, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05). Combined <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> and NMU exposure synergistically dysregulated <italic toggle="yes">Tff2</italic>/<italic toggle="yes">Ghrelin</italic> expression, exacerbated autophagic flux disruption, and impaired stem cell function, reducing organoid budding (decreased 43% vs. <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> alone at 36&#8201;weeks, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01) and dysregulating <italic toggle="yes">CD133</italic>, <italic toggle="yes">CD44</italic>, <italic toggle="yes">Lgr5</italic>, and <italic toggle="yes">SOX2</italic> expression. Pathologically, this combination led to severe gastric damage, including intestinal metaplasia and neutrophil infiltration. Chloroquine (CQ) treatment mitigates these effects by reversing autophagic dysfunction, restoring stem cell capacity (<italic toggle="yes">Lgr5</italic> increased 97% at 44&#8201;weeks, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05), differentially modulating <italic toggle="yes">Tff2</italic>/<italic toggle="yes">Ghrelin</italic>: potentiating <italic toggle="yes">Tff2</italic> and suppressing Ghrelin, normalizing organoid growth, attenuating the EMT, and reducing inflammation, particularly in the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU group. These findings elucidate how <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> and NMU drive gastric pathology through autophagy-stem cell crosstalk and highlight CQ&#8217;s potential as a targeted therapeutic strategy for infection-associated gastric damage.</p></abstract><kwd-group kwd-group-type="author"><title>KEYWORDS</title><kwd><italic toggle="yes">Helicobacter pylori</italic></kwd><kwd>autophagy</kwd><kwd>epithelial-mesenchymal transition (EMT)</kwd><kwd>organoid</kwd><kwd>chloroquine</kwd><kwd>N-nitroso-N-methylurea (NMU)</kwd></kwd-group><support-group><funding-group><award-group><funding-source><institution-wrap><institution>National Natural Science Foundation of China</institution><institution-id institution-id-type="open-funder-registry">10.13039/501100001809</institution-id></institution-wrap></funding-source><award-id>82172560</award-id></award-group><award-group><funding-source><institution-wrap><institution>Taishan Scholar Foundation of Shandong Province, China</institution></institution-wrap></funding-source><award-id>tsqn202211229</award-id></award-group><award-group><funding-source><institution-wrap><institution>special supporting funds for Leading Talents above the Provincial Level in Yantai city, China</institution></institution-wrap></funding-source></award-group><award-group><funding-source><institution-wrap><institution>Yantai Science and Technology Development Project</institution></institution-wrap></funding-source><award-id>2022JCYJ024</award-id></award-group><funding-statement>This work was supported by the National Natural Science Foundation of China under Grant 82172560; the Taishan Scholar Foundation of Shandong Province, China under Grant tsqn202211229; special supporting funds for Leading Talents above the Provincial Level in Yantai city, China; and Yantai Science and Technology Development Project (2022JCYJ024).</funding-statement></funding-group></support-group><counts><fig-count count="7"/><table-count count="1"/><ref-count count="58"/><page-count count="1"/><word-count count="6955"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" disp-level="1" id="s0001"><title>Introduction</title><p>Gastric diseases, including gastritis and gastric cancer, are strongly associated with <italic toggle="yes">Helicobacter pylori</italic> infection, which affects a substantial portion of the global population [<xref rid="cit0001" ref-type="bibr">1</xref>,<xref rid="cit0002" ref-type="bibr">2</xref>]. <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> infection is a key driver of various gastric conditions, ranging from inflammation and ulcers to more severe outcomes such as cancer. This disease is multifactorial, progressing through a complex, prolonged course influenced by various environmental, genetic, and microbial factors [<xref rid="cit0003" ref-type="bibr">3</xref>]. The pathogenicity of <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> involves its ability to deliver virulence factors into host cells, disrupting normal cellular processes, and leading to tissue damage [<xref rid="cit0004" ref-type="bibr">4</xref>,<xref rid="cit0005" ref-type="bibr">5</xref>]. This disruption can cause abnormal stem cell behavior, contributing to both precancerous conditions and cancer development [<xref rid="cit0006" ref-type="bibr">6</xref>,<xref rid="cit0007" ref-type="bibr">7</xref>]. <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> alter stem cell dynamics by inducing uncontrolled proliferation and survival of these cells, laying the foundation for precancerous changes that can lead to the development of gastric cancer [<xref rid="cit0008" ref-type="bibr">8</xref>].</p><p>Stem cells play a critical role in maintaining gastric tissue homeostasis through self-renewal and differentiation [<xref rid="cit0009" ref-type="bibr">9</xref>]. Under normal conditions, these processes are tightly regulated, but <italic toggle="yes">H. pylori</italic> infection can disrupt this balance, leading to altered stem cell dynamics and disease progression [<xref rid="cit0008" ref-type="bibr">8</xref>]. One key factor in this process is autophagy, a cellular degradation pathway that helps regulate stem cell function, tissue repair, and responses to infection [<xref rid="cit0010" ref-type="bibr">10</xref>].</p><p>Autophagy influences gastric stem cell behavior by regulating cellular homeostasis and stress responses, contributing to both inflammation and oncogenesis [<xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0012" ref-type="bibr">12</xref>]. Notably, autophagy interacts with the epithelial &#8211; mesenchymal transition (EMT). The EMT enhances cell migration, invasion, and stemness acquisition [<xref rid="cit0013" ref-type="bibr">13</xref>,<xref rid="cit0014" ref-type="bibr">14</xref>], and its crosstalk with autophagy drives tissue pathology through pathways like PI3K/AKT/mTOR, AMPK, and TGF-&#946; [<xref rid="cit0015" ref-type="bibr">15</xref>]. PI3K/AKT/mTOR hyperactivation suppresses epithelial markers and upregulates mesenchymal markers via Twist/Snail/ZEB1, while its inhibition reverses these effects [<xref rid="cit0016" ref-type="bibr">16</xref>]. AMPK, activated by LKB1 or ghrelin, inhibits mTOR to promote autophagy and suppresses the EMT by targeting Snail and Hedgehog/Gli1 [<xref rid="cit0017" ref-type="bibr">17</xref>]. TGF-&#946; drives the EMT via SMAD/non-SMAD pathways and induces autophagy through BECN1/ATG5/ATG7, with context-dependent outcomes [<xref rid="cit0018" ref-type="bibr">18</xref>]. Notably, these pathways are co-opted during <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> infection, where chronic inflammation disrupts the autophagy &#8211; EMT balance. The loss of epithelial markers (e.g. E-cadherin) and gain of mesenchymal markers (e.g. &#945;-SMA, vimentin) not only facilitate the EMT but also alter stem cell plasticity, promoting gastritis-to-cancer transition [<xref rid="cit0019" ref-type="bibr">19</xref>,<xref rid="cit0020" ref-type="bibr">20</xref>]. This synergy between autophagy dysregulation and EMT activation not only remodels gastric epithelium but also accelerates the Correa cascade, highlighting their dual role as therapeutic targets in <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>-associated carcinogenesis.</p><p>Organoids, which are three-dimensional structures derived from stem cells, have emerged as a powerful tool for studying tissue biology. Organoids replicate the structure and function of real organs, providing an advanced platform for studies [<xref rid="cit0021" ref-type="bibr">21</xref>]. In 2009, small intestinal organoids from <italic toggle="yes">Lgr5</italic><sup>+</sup> stem cells in mice were successfully cultured, demonstrating the potential of organoid technology in research [<xref rid="cit0022" ref-type="bibr">22</xref>]. Based on past studies, the size, number, and budding of organoids serve as important indicators of stem cell dynamics, including their capacities for proliferation, differentiation, and self-renewal, as reported in numerous studies [<xref rid="cit0023" ref-type="bibr">23&#8211;25</xref>]. These morphological features reflect the functional state of stem cells and also provide a model for understanding developmental processes and tissue regeneration, highlighting their relevance in modeling organogenesis and disease. While most studies on <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> -related gastric diseases still rely on traditional two-dimensional cell cultures and mouse models [<xref rid="cit0026" ref-type="bibr">26</xref>], organoids provide a more physiologically relevant system for studying how <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> affect stem cell dynamics during the progression of gastric diseases.</p><p>In recent decades, the link between <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> infection and the progression of gastric diseases, such as gastritis and gastric cancer [<xref rid="cit0027" ref-type="bibr">27</xref>], has been well-established. However, despite extensive research, the interactions between <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>, host cell autophagy, and stem cell dynamics remain only partially understood, particularly in the presence of exposure to carcinogens, which significantly alters the gastric tissue microenvironment. N-nitroso-N-methylurea (NMU), a potent alkylating agent, induces gastric epithelial DNA damage and synergizes with <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>-induced inflammation to model early-stage gastric pathology [<xref rid="cit0028" ref-type="bibr">28</xref>,<xref rid="cit0029" ref-type="bibr">29</xref>]. This study therefore aimed to: (1) clarify how <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> and NMU exposure enhances autophagic activity; (2) reveal how autophagy dysregulation influences the EMT and disrupts stem cell function; and (3) investigate how chloroquine (CQ), an autophagy inhibitor, mitigates pathological changes by restoring normal stem cell function and promoting tissue repair. These findings provide new insights into potential therapeutic approaches for <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>-related gastric diseases and emphasize the importance of targeting autophagy as a novel strategy for various treatments.</p></sec><sec disp-level="1" id="s0002"><title>Materials and methods</title><sec disp-level="2" id="s0002-s2001"><title>Bacterial culture</title><p>The SS1 strain of <italic toggle="yes">Helicobacter pylori</italic>, stored as a glycerol stock at&#8201;&#8722;&#8201;80&#176;C in the Pathogenic Biology Laboratory of Binzhou Medical University, was revived by thawing at room temperature and washing in sterile phosphate-buffered saline (PBS). The revived strain was inoculated by streaking approximately 100&#8201;&#181;L of bacterial suspension onto Karmali agar plates (OXOID, CM0935, GBR), which contained 39.0&#8201;g/L Columbia agar base, 4.0&#8201;g/L activated charcoal, and 32&#8201;mg/L hemin chloride, adjusted to pH 7.2&#8201;&#177;&#8201;0.2 (at 25&#176;C post-sterilization), and supplemented with 5% defibrinated sheep blood. Plates were incubated at 37&#176;C in a three-gas incubator (Thermo, 3131, USA) under microaerophilic conditions (5% O&#8322;, 10% CO&#8322;, 85% N&#8322;). Bacterial growth was monitored every 2&#8211;3&#8201;d, and fresh Kamali agar plates were prepared as needed to maintain optimal growth conditions.</p></sec><sec disp-level="2" id="s0002-s2002"><title>Animal model establishment and sampling</title><p>For this study, 5-week-old male C57BL/6 mice were sourced from Jinan Pengyue Experimental Animal Breeding Co., Ltd. (SCXK Lu 20,190,003, China) and kept in specific pathogen-free facilities with a 12-hour light/dark cycle, at 22&#8201;&#177;&#8201;1&#176;C and 40&#8211;60% humidity. After 1&#8201;week of adaptation, the mice were randomly divided into four groups: Control, <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>, NMU, and <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU (<italic toggle="yes">n</italic>&#8201;=&#8201;45 per group). The initial grouping of mice was performed using a random number table to ensure unbiased allocation. An independent researcher, who was not involved in subsequent experimental procedures, assigned each mouse a unique identifier and allocated them to groups according to the pre-generated random sequence. The Control group received no treatment, while the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> group was administered <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> (SS1 strain) by gastric gavage (0.6&#8201;mL of bacterial suspension at 1&#8201;&#215;&#8201;10<sup>9</sup> cfu/mL) every other day for 3&#8201;weeks. The NMU group was gavaged with NMU (5&#8201;mg/3&#8201;mL, 0.3&#8201;mL) weekly for 10&#8201;weeks. The <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU group received <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> for 3&#8201;weeks, followed by NMU for 10&#8201;weeks. The control group was maintained under identical baseline conditions to the experimental groups, providing reference values for normal physiological parameters throughout the study period. The single-treatment groups (<italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>-only and NMU-only groups) were designed to assess the individual effects of each intervention, whereas the combined treatment group (<italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU) allowed evaluation of potential synergistic effects between the two agents.</p><p>At 41&#8201;weeks of age, mice were further divided into two subgroups: one group receiving phosphate-buffered saline (PBS) gavage (0.5&#8201;mL) and the other receiving intraperitoneal injections of CQ (60&#8201;mg/kg, 0.5&#8201;mL) daily for 1&#8201;week. This resulted in eight groups: Control, <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>, NMU, <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU, Control&#8201;+&#8201;CQ, <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;CQ, NMU&#8201;+&#8201;CQ, and <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU&#8201;+&#8201;CQ. The position of each mouse cage was re-shuffled at the end of intragastric treatment to ensure that there was no fixed order of treatment. Each time, the numbers were re-arranged and processed in a randomly generated sequence to ensure treatment randomization. Intraperitoneal injection was performed in a similar manner. All mouse treatments were performed by two separate individuals, and no specific grouping was given. The weight and hair status of the animals were observed every week. From the end of drug treatment to the end of the experiment, the mice had normal food and water intake, normal hair, and slightly decreased weight; quality of life of the mice was ensured as best as possible.</p><p>Mice were euthanized at 24, 36, and 44&#8201;weeks of age, and gastric tissues were collected for analysis. At 24&#8201;weeks of age, gastric tissues were collected to confirm successful colonization of <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> using Giemsa staining. To confirm <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> colonization and exclude contamination, gastric tissue samples were subjected to PCR amplification of the pathogen-specific <italic toggle="yes">cytotoxin-associated gene A</italic> (<italic toggle="yes">cagA</italic>) gene, a standard virulence marker for <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> identification. Gastric tissues were collected at 24, 36, and 44&#8201;weeks for hematoxylin and eosin staining, and immunohistochemistry analyses for E-cadherin and vimentin. Stem cells were isolated for organoid culture. Subsequently, the development and differentiation of the organoids were examined. At 24 and 44&#8201;weeks, LC3B (microtubule-associated protein 1A/1B-light chain 3B) levels were assessed by immunohistochemistry and autophagosomes/autolysosomes were analyzed by transmission electron microscopy (TEM). For each independent experiment, six samples of stomach tissue were selected from six random mice in each group. No animals died during the experiment.</p><p>The study was approved by the Animal Use and Care Committee of Binzhou Medical University (Approval No. 2021&#8211;012), with all procedures complying with national and international standards for animal care and use. The ethical review process entails a thorough assessment of the experimental protocol, animal welfare provisions, and study endpoints to ensure adherence to institutional and regulatory ethical standards. All procedures were performed in accordance with ARRIVE 2.0 guidelines, with particular attention to randomization, blinding and sample size calculation to ensure robust and unbiased experimental design. A completed ARRIVE checklist has been provided as supplementary material.</p></sec><sec disp-level="2" id="s0002-s2003"><title>Giemsa staining</title><p>Gastric tissues were dissected, and paraffin sections were prepared. Giemsa staining solution was made by diluting concentrated Giemsa solution 1:9. Fresh Giemsa dye solution was prepared, and paraffin was removed with xylene followed by dehydration with gradients of alcohol. The dye was applied to the slides, covering all specimens, and stained for 20&#8201;minutes. After rinsing with tap water, the samples were cleared with gradient alcohol and xylene, sealed with neutral gum, and observed under a light microscope for imaging.</p></sec><sec disp-level="2" id="s0002-s2004"><title>DNA extraction and cagA gene amplification</title><p>Genomic DNA from mouse tissues was extracted using a Tiangen Genomic DNA Extraction Kit (DP304, CHN) according to the manufacturer&#8217;s instructions. DNA was extracted from 0.01&#8201;g of gastric tissue collected from 5-week-old C57BL/6 mice. The tissue was chopped, suspended in 1&#8201;mL of PBS, homogenized using ultrasound, and centrifuged. The resulting pellet was resuspended in 200&#8201;&#956;L of buffer GA, followed by the addition of 4&#8201;&#956;L of RNase A, and incubated at room temperature for 5&#8201;minutes. Then, 20&#8201;&#956;L of proteinase K was added and the mixture was incubated at 56&#176;C for 1 hour. The solution was then treated with buffer GB and ethanol, purified using a spin column, and DNA was isolated for subsequent PCR analysis.</p><p>The <italic toggle="yes">H</italic>. <italic toggle="yes">pylori cagA</italic> gene was amplified using primers <italic toggle="yes">cagA</italic>-F and <italic toggle="yes">cagA-</italic>R (<xref rid="t0001" ref-type="table">Table 1</xref>) designed from the SS1 strain sequence. The 25&#8201;&#956;L PCR reaction consisted of 12.5&#8201;&#956;L mix, 1&#8201;&#956;L of each primer, 1&#8201;&#956;L template DNA, and 9.5&#8201;&#956;L nuclease-free water. The amplification was conducted under the following conditions: initial denaturation at 95&#176;C for 30&#8201;seconds, followed by 40 cycles of 95&#176;C for 30&#8201;seconds, 60&#176;C for 30&#8201;seconds, and 72&#176;C for 1&#8201;minute, with a final extension at 72&#176;C for 10&#8201;minutes. The PCR products were verified using agarose gel electrophoresis.<table-wrap position="float" id="t0001" orientation="portrait"><label>Table 1.</label><caption><p>Primers used in this study.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="1*" align="left" span="1"/><col width="1*" align="center" span="1"/></colgroup><thead><tr><th align="left" colspan="1" rowspan="1">Primer name</th><th align="center" colspan="1" rowspan="1">Primer Sequence</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">cagA</italic>-F</td><td align="center" colspan="1" rowspan="1">5&#8221;-GAGCCTACTGGTGGGGATTG-3&#8221;</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">cagA</italic>-R</td><td align="center" colspan="1" rowspan="1">5&#8221;-TGTGAGCCTGTGAGTTGGTC-3&#8221;</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">GAPDH</italic>-F</td><td align="center" colspan="1" rowspan="1">5&#8221;-AGTATGACTCCACTCACGGCAA-3&#8221;</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">GAPDH</italic>-R</td><td align="center" colspan="1" rowspan="1">5&#8221;-ACACCAGTAGACTCCACGACA-3&#8221;</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">E-cadherin</italic>-F</td><td align="center" colspan="1" rowspan="1">5&#8221;-GATCCTGACCAGCAGTTCGTT-3&#8221;</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">E-cadherin</italic>-R</td><td align="center" colspan="1" rowspan="1">5&#8221;-GGGCTTCATTCACGTCTACCAC-3&#8221;</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Tff2</italic>-F</td><td align="center" colspan="1" rowspan="1">5&#8221;-TCCAAACCAAGAATCGGAGCAG-3&#8221;</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Tff2</italic>-R</td><td align="center" colspan="1" rowspan="1">5&#8221;-ACCCACAATTCTTGCGAGCTGA-3&#8221;</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Ghrelin</italic>-F</td><td align="center" colspan="1" rowspan="1">5&#8221;-ATGCTGTCTTCAGGCACCATC-3&#8221;</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Ghrelin</italic>-R</td><td align="center" colspan="1" rowspan="1">5&#8221;-CTCCTGACAGCTTGATGCCAAC-3&#8221;</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">CD133</italic>-F</td><td align="center" colspan="1" rowspan="1">5&#8221;-CTGGTGGGCTGCTTCTTTTGTATG-3&#8221;</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">CD133</italic>-R</td><td align="center" colspan="1" rowspan="1">5&#8221;-CCGAGTCCTGGTCTGCTGGTTAG-3&#8221;</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">CD44</italic>-F</td><td align="center" colspan="1" rowspan="1">5&#8221;-CACATATTGCTTCAATGCCTCAG-3&#8221;</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">CD44</italic>-R</td><td align="center" colspan="1" rowspan="1">5&#8221;-CCATCACGGTTGACAATAGTTATG-3&#8221;</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Lgr5</italic>-F</td><td align="center" colspan="1" rowspan="1">5&#8221;-GACAATGCTCTCACAGAC-3&#8221;</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Lgr5</italic>-R</td><td align="center" colspan="1" rowspan="1">5&#8221;-GGAGTGGATTCTATTATTATGG-3&#8221;</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">SOX2</italic>-F</td><td align="center" colspan="1" rowspan="1">5&#8221;-GCACATGAACGGCTGGAGCAACG-3&#8221;</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">SOX2</italic>-R</td><td align="center" colspan="1" rowspan="1">5&#8221;-TGCTGCGAGTAGGACATGCTGTAGG-3&#8221;</td></tr></tbody></table></table-wrap></p></sec><sec disp-level="2" id="s0002-s2005"><title>Immunohistochemical staining</title><p>Paraffin-embedded sections of mouse gastric tissue were prepared for immunohistochemistry. Sections were dried at 60&#176;C for 2&#8201;hours, dewaxed, and rehydrated. Following antigen retrieval and peroxidase inactivation, sections were blocked with serum for 15&#8201;minutes. Primary antibodies were incubated overnight at 4&#176;C. Secondary antibody (goat anti-mouse/rabbit IgG polymer; Cell Signaling Technology, USA) was then applied and incubated at 37&#176;C for 30&#8201;minutes. DAB (3,3&#8217;&#8722;diaminobenzidine) solution was used for visualization, with staining observed under a light microscope for 1&#8211;5&#8201;minutes. Hematoxylin counterstaining was performed for 2&#8201;minutes, followed by treatment with 1% hydrochloric acid/alcohol for 5&#8201;seconds. The sections were then rinsed, dehydrated, cleared, and mounted with neutral gum. Under the microscope, nuclei were stained blue-purple and positive regions appeared yellow-brown.</p></sec><sec disp-level="2" id="s0002-s2006"><title>Transmission electron microscopy (TEM)</title><p>Mouse gastric tissues were dissected and fixed in 4% paraformaldehyde for 20&#8201;minutes followed by treatment with 2.5% glutaraldehyde at 4&#176;C for 2&#8201;hours. Tissues were washed in 0.1&#8201;M PBS, then fixed in 1% osmium tetroxide at 4&#176;C for 90&#8201;minutes. After washing, the tissues were dehydrated using graded ethanol (50%, 70%, 80%, 95%, and 100%) and acetone. Tissues were then impregnated with acetone-to-embedding reagent mixtures at ratios of 2:1, then 1:2 at 37&#176;C. Polymerization was conducted by embedding the tissues in resin at 60&#176;C for 48&#8201;hours. Ultrathin sections (70&#8201;nm) were cut, placed on copper grids, and stained with 2% uranyl acetate for 15&#8201;minutes and lead citrate for 5&#8201;minutes. After washing and drying, sections were examined using a transmission electron microscope (Hitachi, HT-7800, Japan).</p></sec><sec disp-level="2" id="s0002-s2007"><title>Gastric organoid culture</title><p>The gastric organoid culture protocol was established based on modified methods from Sato et al. [<xref rid="cit0022" ref-type="bibr">22</xref>] and Sato &amp; Clevers [<xref rid="cit0025" ref-type="bibr">25</xref>]. C57BL/6 mice were euthanized by cervical dislocation following intraperitoneal anesthesia, then sterilized by immersion in 75% alcohol. The stomach was aseptically dissected on a sterile surface maintained on crushed ice, and the luminal contents were thoroughly rinsed with ice-cold Dulbecco&#8217;s phosphate buffered saline (DPBS). The tissue was then transferred to a sterile 10&#8201;cm<sup>2</sup> Petri dish and washed three times with chilled DPBS to remove residual debris. Under sterile conditions, the cleaned gastric tissue was minced into 1&#8211;2&#8201;mm<sup>3</sup> fragments using sterile surgical blades. The pieces were transferred to a centrifuge tube, washed with DPBS by gentle pipetting, and the supernatant was replaced repeatedly until it became clear. The tissue fragments were enzymatically digested at 37&#176;C for 1 hour in a digestion solution containing collagenase IV (1&#8201;mg/mL), hyaluronidase (0.5&#8201;mg/mL), 20% fetal bovine serum (FBS), and 1% penicillin-streptomycin (P/S) in RPMI-1640 base medium (total volume of 10&#8201;mL). The reaction was terminated by adding an equal volume of fresh RPMI-1640 medium. The suspension was filtered twice through a 200-mesh cell strainer to obtain a single-cell suspension, which was centrifuged at 500&#8201;&#215;&#8201;<italic toggle="yes">g</italic> for 10&#8201;minutes at 4&#176;C. The resulting pellet was resuspended in 1640 medium as required for the experiment. The single-cell suspension was mixed 1:1 with Matrigel, seeded at 50&#8201;&#956;L per well in a preheated 24-well plate, and incubated at 37&#176;C for 30&#8201;minutes to facilitate formation of a solid. Organoid medium was subsequently added and the cells were cultured at 37&#176;C in a 5% CO&#8322; incubator with medium changes every 2&#8201;d. Organoid growth was monitored using a light microscope.</p></sec><sec disp-level="2" id="s0002-s2008"><title>Real-time quantitative PCR (qPCR)</title><p>Approximately 0.01&#8201;g of gastric tissue was homogenized in 1&#8201;mL of TRIzol reagent (Invitrogen , USA) and incubated on ice for 30&#8201;minutes. After adding 200&#8201;&#956;L of chloroform, the mixture was shaken for 30&#8201;seconds, left on ice for 3&#8201;minutes, and centrifuged at 12,000&#8201;&#215;&#8201;<italic toggle="yes">g</italic> for 15&#8201;minutes at 4&#176;C. The supernatant was mixed with an equal volume of isopropanol, then incubated at room temperature for 20&#8201;minutes before repeating centrifugation. The resulting RNA pellet was washed with 75% ethanol, air-dried, and dissolved in 20&#8201;&#956;L enzyme-free water. For reverse transcription yielding cDNA, 8&#8201;&#956;L RNA was mixed with 2&#8201;&#956;L enzyme (SparkJade, AG0304, CHN) and incubated at 42&#176;C for 5&#8201;minutes, followed by incubation at 85&#176;C for 5&#8201;minutes. The qPCR reaction mix contained 2.0&#8201;&#956;L cDNA, 0.4&#8201;&#956;L SYBR Green Master Mix (ROX) (SparkJade, AH0104, CHN), 0.4&#8201;&#956;L of forward and reverse primers (<xref rid="t0001" ref-type="table">Table 1</xref>), and 6.8&#8201;&#956;L nuclease-free water, making a total volume of 10&#8201;&#956;L per reaction. The qPCR was performed using a thermal cycler (Thermo Fisher Scientific, USA) with the following program: 50&#176;C for 2&#8201;minutes, 95&#176;C for 30&#8201;seconds, followed by 40 cycles of 95&#176;C for 5&#8201;seconds, and 60&#176;C for 30&#8201;seconds. The number of cycle values were recorded and relative gene expression was calculated using GAPDH as the internal reference.</p></sec><sec disp-level="2" id="s0002-s2009"><title>Haematoxylin and eosin (H&amp;E) staining</title><p>Gastric tissues were washed, sectioned, and fixed in 4% paraformaldehyde for 24&#8201;hours. After rinsing in PBS, the tissues underwent dehydration with graded concentrations of ethanol (75% for 5&#8201;minutes, 85% for 5&#8201;minutes, and 95% twice for 15&#8201;minutes), followed by paraffin embedding and sectioning. Slides were dried and baked at 60&#176;C for 2&#8201;hours before dewaxing and hematoxylin staining for 8&#8201;minutes. Differentiation was conducted with 1% hydrochloric acid/alcohol for 30&#8201;seconds, followed by rinsing, eosin staining for 5&#8201;minutes, and dehydration using anhydrous ethanol. After clearing with xylene, the slides were sealed with neutral gum and viewed using a light microscope.</p></sec><sec disp-level="2" id="s0002-s2010"><title>Statistical analysis</title><p>Quantitative data were expressed as means&#8201;&#177;&#8201;standard deviation (SD) and analyzed using one-way analysis of variance (ANOVA) in SPSS Statistics (version 22.0), and group differences were compared using Bonferroni&#8217;s post hoc test. Statistical charts were created with GraphPad Prism and Adobe Illustrator. Statistical significance was defined as follows: *<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05, **<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01, ***<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001, and ****<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001.</p></sec></sec><sec disp-level="1" id="s0003"><title>Results</title><sec disp-level="2" id="s0003-s2001"><title>H. pylori chronic infection induces autophagy dysregulation in gastric tissue</title><p>Giemsa staining confirmed the presence of <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> in the gastric tissue of infected mice, revealing its characteristic slender, curved, rod-shaped morphology. PCR amplification further identified the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori cagA</italic> gene, and sequencing confirmed the gene sequence. These results demonstrated successful establishment of the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>-infected mouse model (Figure S1).</p><p>To investigate the role of autophagy in gastric tissue during chronic <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> infection, immunohistochemical staining for LC3B was performed (<xref rid="f0001" ref-type="fig">Figure 1A</xref>). LC3B expression in 24-week-old mice was higher in the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> group compared with the control group, and the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU group showed elevated LC3B levels compared with the NMU group. In 44-week-old mice (<xref rid="f0001" ref-type="fig">Figure 1B</xref>), LC3B expression remained higher in the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> group than that in the control group, and the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU group continued to show higher LC3B expression than the NMU group. After CQ treatment, autophagy was inhibited, leading to the accumulation of LC3B. Expression of LC3B was higher in the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;CQ group compared with the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> group, and the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU&#8201;+&#8201;CQ group showed increased LC3B levels relative to the <italic toggle="yes">H. pylori</italic>&#8201;+&#8201;NMU group.
<fig position="float" id="f0001" fig-type="figure" orientation="portrait"><label>Figure 1.</label><caption><p>LC3B accumulation in gastric tissues during chronic <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> infection, N-nitroso-N-methylurea (NMU) treatment, and chloroquine (CQ) treatment. (A) immunohistochemical staining for LC3B in gastric tissues of 24-week-old mice across experimental groups: control, <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>, NMU, <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU (<italic toggle="yes">n</italic>&#8201;=&#8201;6). (B) LC3B expression were observed in 44-week-old mice across experimental groups: control, <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>, NMU, <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU, <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;CQ, and <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU&#8201;+&#8201;CQ (<italic toggle="yes">n</italic>&#8201;=&#8201;6). Scale bar: 100&#8201;&#956;m.</p></caption><alternatives><graphic content-type="color" specific-use="web-only" position="float" orientation="portrait" xlink:href="KVIR_A_2551176_F0001_OC.jpg"/><graphic content-type="black-white" specific-use="print-only" position="float" orientation="portrait" xlink:href="KVIR_A_2551176_F0001_PB.jpg"/></alternatives></fig></p><p>To assess the effects of autophagy at the ultrastructural level, TEM was performed. In 24-week-old mice (<xref rid="f0002" ref-type="fig">Figure 2A</xref>), the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> group showed more pronounced mitochondrial ridge dissolution compared with the NMU group. Ribosome adhesion was observed on the rough endoplasmic reticulum (ER) and cytoplasmic surfaces, with enlarged cisternal spaces and moderate ER expansion accompanied by membrane dissolution. Autophagic lysosomes, enclosed by a single membrane, were also present. In the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU group, ER and cisternal spaces were significantly enlarged, with marked degranulation of cytoplasmic ribosomes. Autophagic lysosomes were observed, indicating more severe autophagy compared with the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> group.
<fig position="float" id="f0002" fig-type="figure" orientation="portrait"><label>Figure 2.</label><caption><p>Accumulation of autophagosomes and autolysosomes in gastric tissues of mice exposed to <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>, N-nitroso-N-methylurea (NMU), and chloroquine. (A) transmission electron microscopy of autophagy-related structures in gastric tissue of 24-week-old mice: control group, <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> group, NMU group, <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU group (<italic toggle="yes">n</italic>&#8201;=&#8201;5 independent fields of view analyzed per group). (B) autophagy-related structures were observed in the stomach tissue of 44-week-old mice under transmission electron microscopy across the following groups: control, <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>, NMU, and <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU. Orange arrows, mitochondria; green arrows, rough endoplasmic reticulum; blue arrows, free lipid droplets; and red arrows, polyvesicular bodies and medullary structures (<italic toggle="yes">n</italic>&#8201;=&#8201;5 independent fields of view analyzed per group).</p></caption><alternatives><graphic content-type="color" specific-use="web-only" position="float" orientation="portrait" xlink:href="KVIR_A_2551176_F0002_OC.jpg"/><graphic content-type="black-white" specific-use="print-only" position="float" orientation="portrait" xlink:href="KVIR_A_2551176_F0002_PB.jpg"/></alternatives></fig></p><p>In 44-week-old mice (<xref rid="f0002" ref-type="fig">Figure 2B</xref>), extensive autophagic lysosomes, coated with a single membrane, were observed in both the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> and <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU groups. These lysosomes contained dissolved cell contents, and the myeloid forms represented the final stage of autophagic hydrolysis. No significant autophagy was seen in the NMU group. After CQ treatment, autolysosome degradation was inhibited, leading to the accumulation of single-membrane autolysosomes with dissolved contents. The <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;CQ group exhibited an increased number of autophagic lysosomes and significant ER dilation with membrane dissolution. Similarly, in the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU&#8201;+&#8201;CQ group, the number of autophagic lysosomes and smooth ER expansion further increased.</p></sec><sec disp-level="2" id="s0003-s2002"><title>CQ treatment attenuates H. pylori- and NMU-mediated EMT</title><p>At both 24 and 36&#8201;weeks of age, immunohistochemistry staining revealed a consistent reduction in the epithelial marker E-cadherin in the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> and <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU groups, when compared with the control and NMU groups. Furthermore, the mesenchymal marker vimentin was significantly elevated in the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> and <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU groups, indicating EMT progression. These changes suggested that <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> infection, especially in combination with NMU, promoted the EMT, leading to alterations in gastric tissue structure (<xref rid="f0003" ref-type="fig">Figure 3A,B</xref>). At later stages of the experiment, the EMT became even more pronounced, with further decreases in E-cadherin and increased vimentin levels in the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> and <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU groups. However, after CQ treatment, the EMT was partially reversed, as shown by higher E-cadherin and lower vimentin expressions in the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;CQ and <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU&#8201;+&#8201;CQ groups, suggesting an improvement in the EMT (<xref rid="f0003" ref-type="fig">Figure 3C</xref>).
<fig position="float" id="f0003" fig-type="figure" orientation="portrait"><label>Figure 3.</label><caption><p>Epithelial&#8211;mesenchymal transition (EMT) in gastric tissues of mice under <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>, N-nitroso-N-methylurea (NMU), and chloroquine (CQ) exposure. (A, B) immunohistochemical staining for E-cadherin and vimentin at 24 and 36&#8201;weeks across experimental groups: control, <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>, NMU, <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU (<italic toggle="yes">n</italic>&#8201;=&#8201;6). (C) immunohistochemical staining for E-cadherin and vimentin at 44&#8201;weeks across experimental groups: control, <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>, NMU, <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU, <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;CQ, and <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU&#8201;+&#8201;CQ. Scale bar: 100&#8201;&#956;m.</p></caption><alternatives><graphic content-type="color" specific-use="web-only" position="float" orientation="portrait" xlink:href="KVIR_A_2551176_F0003_OC.jpg"/><graphic content-type="black-white" specific-use="print-only" position="float" orientation="portrait" xlink:href="KVIR_A_2551176_F0003_PB.jpg"/></alternatives></fig></p></sec><sec disp-level="2" id="s0003-s2003"><title>Changes in E-cadherin, Tff2, and ghrelin expression during gastric organoid development</title><p>Expression of <italic toggle="yes">E-cadherin</italic>, <italic toggle="yes">Tff2</italic>, and <italic toggle="yes">Ghrelin</italic> during gastric organoid development was examined under different treatment conditions (<xref rid="f0004" ref-type="fig">Figure 4</xref>). Compared to controls, <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> infection led to a progressive decrease in <italic toggle="yes">E-cadherin</italic> levels at all time points: 0.71-fold at 24&#8201;weeks, 0.64-fold at 36&#8201;weeks, and 0.62-fold at 44&#8201;weeks. The combination of <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> and NMU further reduced <italic toggle="yes">E-cadherin</italic> at 24&#8201;weeks. However, treatment with CQ restored <italic toggle="yes">E-cadherin</italic> expression, with the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;CQ group reaching 2.35-fold and the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU&#8201;+&#8201;CQ group showing a 1.62-fold increase, consistent with immunohistochemical findings.
<fig position="float" id="f0004" fig-type="figure" orientation="portrait"><label>Figure 4.</label><caption><p><italic toggle="yes">E-cadherin</italic>, <italic toggle="yes">Ghrelin</italic>, and <italic toggle="yes">Tff2</italic> expression profiles in mouse gastric organoid. Quantitative PCR analysis of <italic toggle="yes">E-cadherin</italic>, <italic toggle="yes">Ghrelin</italic>, and <italic toggle="yes">Tff2</italic> mRNA expression levels in gastric organoids from mice at (A) 24, (B) 36, and (C) 44&#8201;weeks post-treatment (<italic toggle="yes">n</italic>&#8201;=&#8201;3). Statistical significance: *<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05, **<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01, ***<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001, ****<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001.</p></caption><graphic content-type="black-white" position="float" orientation="portrait" xlink:href="KVIR_A_2551176_F0004_B.jpg"/></fig></p><p>To investigate the link between <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>-induced autophagy and the EMT, <italic toggle="yes">Tff2,</italic> and <italic toggle="yes">Ghrelin</italic> expression was quantified: At 24&#8201;weeks, <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> significantly suppressed both genes versus controls. The <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU group showed further reductions compared to NMU alone (&#916;<italic toggle="yes">Tff2</italic>: &#8722;25%; &#916;<italic toggle="yes">Ghrelin</italic>: &#8722;36%; <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01). By 36&#8201;weeks, <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> infection induced divergent effects: <italic toggle="yes">Tff2</italic> became elevated, while <italic toggle="yes">Ghrelin</italic> remained suppressed. The <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU group exhibited synergistic upregulation of <italic toggle="yes">Tff2</italic>. At 44&#8201;weeks, all treatment groups showed marked <italic toggle="yes">Tff2</italic> upregulation (<italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>: 2.18-fold; NMU: 2.15-fold; <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01 vs. control). CQ treatment differentially modulated this response, potentiating <italic toggle="yes">Tff2</italic> in the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU&#8201;+&#8201;CQ group but suppressing <italic toggle="yes">Ghrelin</italic>.</p></sec><sec disp-level="2" id="s0003-s2004"><title>H. pylori and NMU alter gastric organoid morphology and budding capacity</title><p>To evaluate the proliferative capacity of gastric cancer stem cells, these cells were isolated from mice and cultured as gastric organoids (<xref rid="f0005" ref-type="fig">Figure 5A,E,I</xref>). At 24&#8201;weeks, organoid diameters in the combined exposure group (<italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU, 53.52&#8201;&#177;&#8201;12.33&#8201;&#181;m) were significantly smaller compared to the single exposure groups (<italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>, 74.23&#8201;&#177;&#8201;14.28&#8201;&#181;m; NMU, 69.9&#8201;&#177;&#8201;18.79&#8201;&#181;m; both, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001) (<xref rid="f0005" ref-type="fig">Figure 5B</xref>). By 36&#8201;weeks, the inhibitory effect was more pronounced, with the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU group (48.70&#8201;&#177;&#8201;11.62&#8201;&#181;m) exhibiting significantly smaller organoids compared to the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> or NMU group alone (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01) (<xref rid="f0005" ref-type="fig">Figure 5F</xref>). At 44&#8201;weeks, treatment with the autophagy inhibitor CQ partially reversed this inhibition, with the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU&#8201;+&#8201;CQ group (70.63&#8201;&#177;&#8201;14.66&#8201;&#181;m) showing a recovery in diameter, approaching that of the single CQ-treated groups. Moreover, the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;CQ group (93.74&#8201;&#177;&#8201;18.22&#8201;&#181;m) exhibited the largest diameters among all CQ-treated conditions (<xref rid="f0005" ref-type="fig">Figure 5J</xref>).
<fig position="float" id="f0005" fig-type="figure" orientation="portrait"><label>Figure 5.</label><caption><p>Gastric organoid growth and budding dynamics following <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>, N-nitroso-N-methylurea (NMU), and chloroquine exposure. (A, E, I) Representative images of gastric organoids at 24, 36, and 44&#8201;weeks. Scale bar: 500&#8201;&#956;m. (B, F, J) comparisons of organoid diameters across experimental groups. (C, G, K) organoid number comparisons across different conditions. (D, H, L) budding analysis of gastric organoids under various treatments. The number of organoids is the total number of organoids in a single well of 24-well cell culture plate (<italic toggle="yes">n</italic>&#8201;=&#8201;6). Statistical significance: *<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05, **<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01, ***<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001, ****<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001.</p></caption><alternatives><graphic content-type="color" specific-use="web-only" position="float" orientation="portrait" xlink:href="KVIR_A_2551176_F0005_OC.jpg"/><graphic content-type="black-white" specific-use="print-only" position="float" orientation="portrait" xlink:href="KVIR_A_2551176_F0005_PB.jpg"/></alternatives></fig></p><p>Organoid numbers followed a similar trend of modulation across exposure groups (<xref rid="f0005" ref-type="fig">Figure 5C,G,K</xref>). At 24&#8201;weeks, the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> group (66.00&#8201;&#177;&#8201;4.32) exhibited significantly higher organoid numbers compared with the control group (34.33&#8201;&#177;&#8201;4.03; <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001), while NMU also increased organoid numbers (50.67&#8201;&#177;&#8201;2.49). In contrast, the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU group (64.67&#8201;&#177;&#8201;3.40) showed no significant difference from the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> group alone. At 36&#8201;weeks, organoid numbers in the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU group (47.67&#8201;&#177;&#8201;2.05) were significantly lower than in the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> group (61.33&#8201;&#177;&#8201;2.49; <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001), highlighting a potential inhibitory interaction between <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> and NMU. By 44&#8201;weeks, CQ treatment elicited distinct effects, with the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;CQ group (58.00&#8201;&#177;&#8201;1.63) exhibiting the highest organoid numbers after treatment. In contrast, the NMU&#8201;+&#8201;CQ group (28.00&#8201;&#177;&#8201;1.63) showed a further decline in organoid numbers, and the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU&#8201;+&#8201;CQ group (41.33&#8201;&#177;&#8201;2.49) showed only a slight increase compared with the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU group without CQ.</p><p>Organoid budding varied across groups and time points (<xref rid="f0005" ref-type="fig">Figure 5D,H,L</xref>). At 24&#8201;weeks, the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU group (0.57&#8201;&#177;&#8201;0.07% budding) showed a notable reduction, when compared with the NMU group (0.73&#8201;&#177;&#8201;0.01%). By 36&#8201;weeks, the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> group (0.83&#8201;&#177;&#8201;0.04%) maintained the highest budding percent, while the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU group showed a significant decline (0.47&#8201;&#177;&#8201;0.02%; <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01) compared with NMU treatments. At 44&#8201;weeks, the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU group showed reduced budding (0.61&#8201;&#177;&#8201;0.06%), which was significantly lower than either single exposure group (all, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05). CQ treatment further influenced budding. The <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;CQ group had the highest budding (0.88&#8201;&#177;&#8201;0.02%; <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001), while the NMU&#8201;+&#8201;CQ group (0.70&#8201;&#177;&#8201;0.01%) displayed a slight but significant increase over NMU alone (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05). However, the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU&#8201;+&#8201;CQ group (0.55&#8201;&#177;&#8201;0.04%) showed no improvement compared with the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU group.</p></sec><sec disp-level="2" id="s0003-s2005"><title>H. pylori and NMU modulate gastric stem cell markers through CQ-sensitive pathways</title><p>To determine the expressions of gastric stem cell markers, qRT-PCR was performed to evaluate mRNA levels of <italic toggle="yes">CD133</italic>, <italic toggle="yes">CD44</italic>, <italic toggle="yes">Lgr5</italic>, and <italic toggle="yes">SOX2</italic> in mice at different ages (<xref rid="f0005" ref-type="fig">Figure 5</xref>).</p><p>At 24&#8201;weeks, the mRNA expression levels of <italic toggle="yes">CD44</italic>, <italic toggle="yes">CD133</italic>, <italic toggle="yes">Lgr5</italic>, and <italic toggle="yes">SOX2</italic> showed distinct changes in the experimental groups (<xref rid="f0006" ref-type="fig">Figure 6A</xref>). Compared to the control group, <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> treatment significantly increased the expression levels of <italic toggle="yes">CD44</italic>, <italic toggle="yes">Lgr5</italic>, and <italic toggle="yes">SOX2</italic> by approximately 35%, 92%, and 81%, respectively (all, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05), while the expression of <italic toggle="yes">CD133</italic> showed no significant difference. NMU treatment alone significantly decreased expression levels of <italic toggle="yes">CD44</italic> and <italic toggle="yes">CD133</italic> by 35% and 30%, respectively, while <italic toggle="yes">Lgr5</italic> levels increased by 85% (all, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05). The combined treatment of <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU exhibited unique expression patterns. Compared to the NMU group, the <italic toggle="yes">CD44</italic> and <italic toggle="yes">CD133</italic> levels significantly increased, while <italic toggle="yes">SOX2</italic> expression was significantly reduced, when compared with the <italic toggle="yes">H. pylori</italic> group (all, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05). Together, these results indicated that combined <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU treatment modulated mRNA expression differently, enhancing the levels of <italic toggle="yes">CD44</italic> and <italic toggle="yes">CD133</italic> relative to NMU treatment alone, while suppressing <italic toggle="yes">SOX2</italic>, compared with <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> treatment alone.
<fig position="float" id="f0006" fig-type="figure" orientation="portrait"><label>Figure 6.</label><caption><p>Expression of gastric stem cell markers in mice following <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>, N-nitroso-N-methylurea, and chloroquine exposure. expression level of <italic toggle="yes">CD44</italic>, <italic toggle="yes">CD133</italic>, <italic toggle="yes">Lgr5</italic>, and <italic toggle="yes">SOX2</italic> at (A) 24, (B) 36, and (C) 44&#8201;weeks of mice in each group was detected by qPCR (<italic toggle="yes">n</italic>&#8201;=&#8201;3). Statistical significance: *<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05, **<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01, ***<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001, ****<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001.</p></caption><alternatives><graphic content-type="color" specific-use="web-only" position="float" orientation="portrait" xlink:href="KVIR_A_2551176_F0006_OC.jpg"/><graphic content-type="black-white" specific-use="print-only" position="float" orientation="portrait" xlink:href="KVIR_A_2551176_F0006_PB.jpg"/></alternatives></fig></p><p>At 36&#8201;weeks, the mRNA expression levels of <italic toggle="yes">CD44</italic>, <italic toggle="yes">CD133</italic>, <italic toggle="yes">Lgr5</italic>, and <italic toggle="yes">SOX2</italic> exhibited notable changes in the experimental groups (<xref rid="f0006" ref-type="fig">Figure 6B</xref>). Both <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> and NMU treatments alone significantly increased the mRNA levels of these molecules, when compared with the Control group (all, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05), with the exception of <italic toggle="yes">SOX2</italic>, which showed no significant change after NMU exposure. Specifically, the mRNA levels of <italic toggle="yes">CD44</italic> and <italic toggle="yes">Lgr5</italic> in the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> group increased by approximately 65% and 246%, respectively, while NMU exposure elevated levels of <italic toggle="yes">CD44</italic> and <italic toggle="yes">Lgr5</italic> by 44% and 86%, respectively. <italic toggle="yes">SOX2</italic> levels increased significantly (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05) in the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> group by 69%. In the combined <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU treatment group, distinct trends were observed. The mRNA levels of <italic toggle="yes">CD133</italic>, <italic toggle="yes">Lgr5</italic>, and <italic toggle="yes">SOX2</italic> were significantly reduced compared with the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> group alone (all, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05), indicating a suppressive effect of combined exposure. Notably, <italic toggle="yes">CD44</italic> expression in the combined group was significantly higher than in the NMU group (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05), whereas <italic toggle="yes">CD133</italic> expression was significantly lower (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01), when compared with NMU alone. Together, these results showed that combined exposure to <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> and NMU modulated mRNA expression of these molecules differently than individual treatments, suggesting potential interactions between these treatments during alterations of gene expressions.</p><p>At 44&#8201;weeks, mRNA expression levels of <italic toggle="yes">CD44</italic>, <italic toggle="yes">CD133</italic>, <italic toggle="yes">Lgr5</italic>, and <italic toggle="yes">SOX2</italic> showed significant variations in different treatment groups (<xref rid="f0006" ref-type="fig">Figure 6C</xref>). Exposure to <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> alone increased <italic toggle="yes">CD44</italic> expression by 37% compared with the control group, while <italic toggle="yes">Lgr5</italic> levels were reduced by approximately 32% (both, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05). When CQ was administered with <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>, <italic toggle="yes">CD44</italic> levels decreased by 49%, and <italic toggle="yes">Lgr5</italic> levels increased by 77%, indicating a notable reversal of the effects induced by <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> alone. In the NMU-treated group, <italic toggle="yes">CD133</italic> and <italic toggle="yes">SOX2</italic> levels rose by 65% and 74%, respectively, while <italic toggle="yes">Lgr5</italic> levels were reduced by nearly 48% compared with the control (all, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01). The addition of CQ to NMU-treated groups caused <italic toggle="yes">CD133</italic> expression to decrease (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001) by approximately 57%, showing a pronounced inhibitory effect. For the combined <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU exposure group, the addition of CQ resulted in significant changes. <italic toggle="yes">CD44</italic> and <italic toggle="yes">CD133</italic> levels decreased by 55% and 50% (both, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001), respectively, relative to the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU group without CQ, while <italic toggle="yes">Lgr5</italic> and <italic toggle="yes">SOX2</italic> levels rose by 97% and 47%, respectively (both, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05). Taken together, these findings suggested that CQ modulated mRNA expression patterns induced by <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> and NMU, and also had variable effects on different molecules, either amplifying or attenuating their expression changes.</p></sec><sec disp-level="2" id="s0003-s2006"><title>Autophagy inhibition by CQ reduces H. pylori- and NMU-induced gastric pathology</title><p>At 24&#8201;weeks of age, H&amp;E staining revealed that the control group had a normal gastric structure with no inflammatory cell infiltration. In contrast, the NMU group showed clear inflammatory infiltration at the base of the mucosal layer, while the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU group exhibited mild structural abnormalities, including dilation of gastric pits and fundic glands, with significant neutrophil infiltration in the submucosa (<xref rid="f0007" ref-type="fig">Figure 7A</xref>). At 36&#8201;weeks, the Control group maintained a normal gastric structure without inflammation. However, the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> group showed gastric mucosal atrophy, glandular expansion, and inflammatory infiltration. The NMU group displayed more pronounced inflammation, while the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU group showed abnormal gastric structure, with glandular dilation, intestinal metaplasia, and heavy neutrophil infiltration (<xref rid="f0007" ref-type="fig">Figure 7B</xref>). By 44&#8201;weeks, the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> group demonstrated moderate gastric atrophy, epithelial exfoliation, and increased inflammatory infiltration. In the NMU group, severe glandular abnormalities and inflammation were observed. The <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU group had extensive glandular expansion, intestinal metaplasia, and heavy neutrophil infiltration. After CQ treatment, both the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;CQ and <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU&#8201;+&#8201;CQ groups showed reduced inflammation and glandular dilation, with necrotic areas appearing in the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU&#8201;+&#8201;CQ group (<xref rid="f0007" ref-type="fig">Figure 7C</xref>).
<fig position="float" id="f0007" fig-type="figure" orientation="portrait"><label>Figure 7.</label><caption><p>Histopathological changes in gastric tissues of mice under <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>, N-nitroso-N-methylurea, and chloroquine exposure. histopathological changes were observed at (A) 24&#8201;weeks, (B) 36&#8201;weeks, and (C) 44&#8201;weeks. Inflammatory cell infiltration (blue), glandular swelling and expansion (red), intestinal metaplasia (orange), glandular shedding (green), and tissue necrosis (black) are indicated by their respective rectangles (<italic toggle="yes">n</italic>&#8201;=&#8201;6). Scale bar: 100&#8201;&#956;m.</p></caption><alternatives><graphic content-type="color" specific-use="web-only" position="float" orientation="portrait" xlink:href="KVIR_A_2551176_F0007_OC.jpg"/><graphic content-type="black-white" specific-use="print-only" position="float" orientation="portrait" xlink:href="KVIR_A_2551176_F0007_PB.jpg"/></alternatives></fig></p></sec></sec><sec disp-level="1" id="s0004"><title>Discussion</title><p>Autophagy modulates the host response to chronic <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> infection, with the bacteria inducing autophagy in gastric epithelial cells. This occurs through mechanisms like VacA-mediated incomplete autophagosome formation and Beclin1-Vps34-dependent activation, promoting both host defense and bacterial persistence [<xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0030" ref-type="bibr">30&#8211;34</xref>]. Our study showed that <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> and NMU co-exposure upregulated LC3B expression and increased autophagic structures, particularly in the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU group, indicating NMU amplifies autophagy to sustain infection (<xref rid="f0001 f0002" ref-type="fig">Figure 1, 2</xref>). Chloroquine (CQ), an autophagy inhibitor, mitigated these effects by blocking autophagic degradation and reducing <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> virulence, as evidenced by LC3B accumulation. These findings align with clinical observations of LC3 overexpression in 58% of human gastric cancers, where elevated LC3 levels correlate with advanced stage and poor prognosis [<xref rid="cit0035" ref-type="bibr">35</xref>,<xref rid="cit0036" ref-type="bibr">36</xref>]. The clinical potential of autophagy inhibition is further supported by Phase I/II trials demonstrating good tolerance and efficacy of CQ derivatives in combination therapies for various cancers [<xref rid="cit0037" ref-type="bibr">37</xref>]. These results provide a strong rationale for exploring CQ-based autophagy-targeted therapies in <italic toggle="yes">H</italic>. <italic toggle="yes">pylori-</italic>related gastric diseases, particularly for treatment-resistant infections or high-risk patients with precancerous lesions.</p><p>The EMT is a critical process in tumor progression, particularly in the migration and invasion of cancer cells [<xref rid="cit0038" ref-type="bibr">38</xref>]. Our study demonstrated that <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> infection and NMU exposure significantly enhanced the EMT in gastric tissue, as indicated by the decreased expression of E-cadherin, reflecting a stronger shift from epithelial to mesenchymal cells (<xref rid="f0003" ref-type="fig">Figure 3</xref>). This EMT induction suggests pathological stem cell differentiation, contributing to tumor progression and disrupted tissue homeostasis [<xref rid="cit0039" ref-type="bibr">39</xref>,<xref rid="cit0040" ref-type="bibr">40</xref>]. Our data reveal that <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> infection disrupts gastric homeostasis by co-ordinately suppressing <italic toggle="yes">Ghrelin</italic> and <italic toggle="yes">E-cadherin</italic> while later inducing <italic toggle="yes">Tff2</italic>&#8212;a pattern exacerbated by NMU co-treatment (<xref rid="f0004" ref-type="fig">Figure 4</xref>). The <italic toggle="yes">Ghrelin</italic> downregulation likely impairs AMPK-mediated autophagy and activates mTOR [<xref rid="cit0015" ref-type="bibr">15</xref>], promoting the EMT through Snail/Twist upregulation and E-cadherin degradation [<xref rid="cit0041" ref-type="bibr">41</xref>]. Conversely, the sustained <italic toggle="yes">Tff2</italic> overexpression &#8211; potentiated by <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU &#8211; may drive &#946;-catenin nuclear translocation, as evidenced in pancreatic models, where TFF2/&#946;-catenin complexes upregulate EMT effectors and inhibit apoptosis [<xref rid="cit0042" ref-type="bibr">42</xref>]. CQ&#8217;s differential effects (rescuing <italic toggle="yes">E-cadherin</italic> but amplifying <italic toggle="yes">Tff2</italic>) suggest autophagy inhibition preferentially blocks the Ghrelin-AMPK-EMT axis while permitting &#946;-catenin-mediated Tff2 signaling. This duality underscores a crosstalk between Ghrelin-autophagy and Tff2/&#946;-catenin pathways in <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>-induced EMT, where Ghrelin loss exacerbates mucosal injury while Tff2 elevation may facilitate pre-neoplastic plasticity. Clinically, EMT drives invasiveness and drug resistance in <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>-related gastric cancer, as seen in pazopanib-treated xenografts with upregulated cancer stem cell markers</p><p>. Targeting the EMT with autophagy inhibitors may reduce tumor progression and overcome resistance.</p><p><italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> infection promotes gastric cancer via chronic inflammation, genotoxic stress, and gastric stem cell dysregulation [<xref rid="cit0043" ref-type="bibr">43</xref>]. It also enhances epithelial proliferation and synergizes with carcinogens to drive aberrant stem cell behavior [<xref rid="cit0044" ref-type="bibr">44</xref>,<xref rid="cit0045" ref-type="bibr">45</xref>]. In this study, <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> significantly increased organoid size, number, and budding, with peak effects at 36&#8201;weeks (<xref rid="f0005" ref-type="fig">Figure 5</xref>). This persistent stem cell activation underscores the role of <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> as an early carcinogenic driver. Combined <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> and NMU exposure initially showed synergistic effects, but over time, resulted in suppression of organoid size, number, and budding, particularly by 44&#8201;weeks (<xref rid="f0005" ref-type="fig">Figure 5</xref>). This suppression likely results from synergistic inflammation and genotoxicity, collectively disrupting stem cell homeostasis and accelerating gastric pathology [<xref rid="cit0046" ref-type="bibr">46</xref>]. These findings suggest that combined exposure altered stem cell behavior and also expedited the progression of precancerous lesions to malignancy. Autophagy, with protective and tumor-promoting roles in gastric stem cell regulation [<xref rid="cit0047" ref-type="bibr">47</xref>], enhances <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>-induced Wnt/&#946;-catenin signaling and organoid growth [<xref rid="cit0048" ref-type="bibr">48</xref>]. However, in the <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU co-exposure model, CQ only partially alleviated suppression and failed to restore organoid morphology, suggesting that the combined inflammatory and genotoxic stress overwhelms the protective capacity of autophagy. These findings highlight the need for therapeutic strategies that simultaneously target both pathogenic pathways in gastric carcinogenesis.</p><p>Bacterial infections and carcinogens can drive cancer progression by disrupting stem cell function [<xref rid="cit0049" ref-type="bibr">49</xref>]. Our study showed that <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> and NMU significantly altered gastric stem cell markers, impacting stem cell regulation (<xref rid="f0006" ref-type="fig">Figure 6</xref>). <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> infection increased <italic toggle="yes">CD44</italic> and <italic toggle="yes">Lgr5</italic> expression, which are linked to stem cell self-renewal and gastric gland regeneration, respectively, consistent with its role in promoting stem cell proliferation during chronic inflammation [<xref rid="cit0050" ref-type="bibr">50</xref>,<xref rid="cit0051" ref-type="bibr">51</xref>] and creating a carcinogenic microenvironment [<xref rid="cit0052" ref-type="bibr">52</xref>]. NMU initially upregulated <italic toggle="yes">Lgr5</italic>, likely for tissue repair, but later suppressed differentiation markers like <italic toggle="yes">SOX2</italic>, reflecting its genotoxic effect on the stem cell niche [<xref rid="cit0045" ref-type="bibr">45</xref>]. Combined <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> and NMU exposure intensified these effects, elevating <italic toggle="yes">CD44</italic> and <italic toggle="yes">CD133</italic> while reducing <italic toggle="yes">Lgr5</italic>, indicating disrupted stem cell dynamics. CQ treatment mitigated these changes by reducing <italic toggle="yes">CD44</italic> and <italic toggle="yes">CD133</italic>, while restoring <italic toggle="yes">Lgr5</italic> and <italic toggle="yes">SOX2</italic> expression, promoting epithelial differentiation and normal stem cell function, consistent with autophagy inhibition reducing pathological proliferation [<xref rid="cit0053" ref-type="bibr">53</xref>,<xref rid="cit0054" ref-type="bibr">54</xref>]. These findings highlight the role of autophagy in mediating <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>- and NMU-driven stem cell changes, suggesting a therapeutic approach to counter inflammation-driven carcinogenesis.</p><p>Previous studies have reported that autophagy inhibition by CQ regulates necrosis and promotes tissue repair in various cell types and during bacterial infections [<xref rid="cit0055" ref-type="bibr">55</xref>]. <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> infection and NMU exposure caused significant gastric tissue damage, including inflammation, glandular dilation, and disruption. Combined exposure intensified these effects, leading to intestinal metaplasia and increased neutrophil infiltration, indicating a synergistic role in gastric injury. CQ, an autophagy inhibitor, reduced inflammation and glandular dilation in both <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> and <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>&#8201;+&#8201;NMU groups, suggesting autophagy drives damage from chronic infection and carcinogen exposure (<xref rid="f0007" ref-type="fig">Figure 7</xref>). CQ inhibited autophagic degradation, reducing uncontrolled autophagy, inflammation, and promoting tissue recovery [<xref rid="cit0056" ref-type="bibr">56</xref>]. By shifting cellular responses from excessive autophagy to controlled necrosis, CQ facilitated damaged cell clearance, reduced neutrophil infiltration, and restored gastric gland structure [<xref rid="cit0057" ref-type="bibr">57</xref>,<xref rid="cit0058" ref-type="bibr">58</xref>]. This suggests the potential of CQ as a therapeutic agent for managing <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>-induced gastric damage, especially with carcinogenic co-exposure.</p><p>This study has two key limitations that warrant further investigation. First, while mouse models provide mechanistic insights, they may not fully replicate human <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> pathogenesis, requiring cautious clinical translation and phase I trials to assess long-term CQ safety (including gastrointestinal and microbiome effects). Additionally, although our 24&#8211;44&#8201;weeks of observation captured early pathology, longer durations are needed to monitor progression to advanced preneoplastic stages. Future studies should therefore: (1) establish longer-term preclinical models to delineate the complete temporal dynamics of <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>- and NMU-driven carcinogenesis, and (2) systematically evaluate combined CQ with targeted anti-inflammatory/genotoxic therapies on stem cell regulation and disease progression.</p></sec><sec disp-level="1" id="s0005"><title>Conclusion</title><p>This study systematically elucidated the critical role of autophagy regulation in the pathogenesis of <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic>-associated gastric diseases. Our findings demonstrate that <italic toggle="yes">H</italic>. <italic toggle="yes">pylori</italic> infection disrupts gastric stem cell homeostasis by activating autophagy pathways, leading to abnormal proliferation, self-renewal, and differentiation of stem cells. Co-exposure with the carcinogen NMU exacerbates this process through synergistic promotion of inflammatory responses and genotoxic stress, accelerating EMT and gastric mucosal pathological changes. Although CQ partially restored stem cell function and alleviated tissue damage by inhibiting autophagy, its limited efficacy in reversing severe pathological remodeling suggests the constraints of autophagy-targeted monotherapy. Based on these findings, we recommend the following future research focus: 1) development of more human-relevant mouse models with extended observation periods; and 2) exploration of combination therapies of autophagy inhibitors with anti-inflammatory or anti-genotoxic agents.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="SM4587" position="float" content-type="local-data" orientation="portrait"><caption><title>Author Checklist.pdf</title></caption><media xlink:href="KVIR_A_2551176_SM4587.pdf" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ack><title>Acknowledgements</title><p>We thank International Science Editing (<ext-link xlink:href="http://www.internationalscienceediting.com" ext-link-type="uri">http://www.internationalscienceediting.com</ext-link>) for editing this manuscript.</p><p>Jing Li and Sisi Liu contributed equally as first authors, leading the original draft writing, data acquisition, and investigation. Zhiqin Li and Chunlei Ma contributed to the investigation and formal analysis. Yingzi Cui handled software implementation and methodology. Wenke Wang supported data curation. Huilin Zhao and Xiaofei Ji contributed to data acquisition and analysis. Boqing Li and Ying Zhang designed and supervised the study, provided resources, contributed to data interpretation, and managed project administration. All authors contributed to manuscript revisions and editing and approved the final manuscript.</p></ack><sec sec-type="COI-statement" disp-level="1" id="s0006"><title>Disclosure statement</title><p>No potential conflict of interest was reported by the author(s).</p></sec><sec sec-type="data-availability" disp-level="1" id="s0007"><title>Data availability statement</title><p>The data generated during the study is available at <ext-link xlink:href="https://doi.org/10.6084/m9.figshare.29579378" ext-link-type="uri">https://doi.org/10.6084/m9.figshare.29579378</ext-link>.</p></sec><sec sec-type="supplementary-material" disp-level="1" id="s0008"><title>Supplemental data</title><p>Supplemental data for this article can be accessed online at <ext-link xlink:href="https://doi.org/10.1080/21505594.2025.2551176" ext-link-type="uri">https://doi.org/10.1080/21505594.2025.2551176</ext-link>.</p></sec><ref-list><title>References</title><ref id="cit0001"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Correa</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Piazuelo</surname><given-names>MB.</given-names></string-name></person-group><article-title><italic toggle="yes">Helicobacter pylori</italic> infection and gastric adenocarcinoma</article-title>. <source>US Gastroenterol Hepatol Rev</source>. <year>2011</year>;<volume>7</volume>(<issue>1</issue>):<fpage>59</fpage>&#8211;<lpage>16</lpage>.<pub-id pub-id-type="pmid">21857882</pub-id><pub-id pub-id-type="pmcid">PMC3158605</pub-id></mixed-citation></ref><ref id="cit0002"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kusters</surname><given-names>JG</given-names></string-name>, <string-name name-style="western"><surname>van Vliet</surname><given-names>AHM</given-names></string-name>, <string-name name-style="western"><surname>Kuipers</surname><given-names>EJ</given-names></string-name></person-group>. <article-title>Pathogenesis of <italic toggle="yes">helicobacter pylori</italic> infection</article-title>. <source>Clin Microbiol Rev</source>. <year>2006</year>;<volume>19</volume>(<issue>3</issue>):<fpage>449</fpage>&#8211;<lpage>490</lpage>. doi: <pub-id pub-id-type="doi">10.1128/CMR.00054-05</pub-id><pub-id pub-id-type="pmid">16847081</pub-id><pub-id pub-id-type="pmcid">PMC1539101</pub-id></mixed-citation></ref><ref id="cit0003"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sano</surname><given-names>T</given-names></string-name></person-group>. <article-title>Gastric cancer: asia and the world</article-title>. <source>Gastric Cancer</source>. <year>2017</year>;<volume>20</volume>(<issue>Suppl S1</issue>):<fpage>1</fpage>&#8211;<lpage>2</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10120-017-0694-9</pub-id><pub-id pub-id-type="pmid">28144923</pub-id></mixed-citation></ref><ref id="cit0004"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tegtmeyer</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Backert</surname><given-names>N</given-names></string-name></person-group>. <article-title><italic toggle="yes">Helicobacter pylori</italic> infection of AZ-521 cells reveals a type IV secretion defect and VacA-independent CagA phosphorylation</article-title>. <source>FEBS J</source>. <year>2017</year>;<volume>284</volume>(<issue>10</issue>):<fpage>1428</fpage>&#8211;<lpage>1441</lpage>. doi: <pub-id pub-id-type="doi">10.1242/dmm.032813</pub-id><pub-id pub-id-type="pmcid">PMC5769614</pub-id><pub-id pub-id-type="pmid">29259027</pub-id></mixed-citation></ref><ref id="cit0005"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tegtmeyer</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Backert</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Rohde</surname><given-names>M</given-names></string-name></person-group>. <article-title>Role of the <italic toggle="yes">Helicobacter pylori</italic> cag-pathogenicity island in gastric border cell signaling and cytoskeleton reorganization</article-title>. <source>Gut Microbes</source>. <year>2011</year>;<volume>2</volume>(<issue>4</issue>):<fpage>230</fpage>&#8211;<lpage>234</lpage>.</mixed-citation></ref><ref id="cit0006"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Loomis</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>G</given-names></string-name></person-group>. <article-title>The International Agency for Research on Cancer (IARC) evaluation of the carcinogenicity of outdoor air pollution: focus on China</article-title>. <source>Chin J Cancer</source>. <year>2014</year>;<volume>33</volume>(<issue>4</issue>):<fpage>189</fpage>&#8211;<lpage>196</lpage>. doi: <pub-id pub-id-type="doi">10.5732/cjc.014.10028</pub-id><pub-id pub-id-type="pmid">24694836</pub-id><pub-id pub-id-type="pmcid">PMC3975184</pub-id></mixed-citation></ref><ref id="cit0007"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wang</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Meng</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>B</given-names></string-name>, et al</person-group>. <article-title><italic toggle="yes">Helicobacter pylori</italic>-induced gastric inflammation and gastric cancer</article-title>. <source>Cancer Lett</source>. <year>2014</year>;<volume>345</volume>(<issue>2</issue>):<fpage>196</fpage>&#8211;<lpage>202</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.canlet.2013.08.016</pub-id><pub-id pub-id-type="pmid">23981572</pub-id></mixed-citation></ref><ref id="cit0008"><label>[8]</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Wizenty</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Sigal</surname><given-names>M</given-names></string-name></person-group>. <part-title>Gastric stem cell biology and <italic toggle="yes">Helicobacter pylori</italic> infection</part-title>: <source>Curr Top Microbiol Immunol</source>. <year>2023</year>.doi:<pub-id pub-id-type="doi">10.1007/978-3-031-47331-9_1</pub-id><pub-id pub-id-type="pmid">38231213</pub-id></mixed-citation></ref><ref id="cit0009"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Liu</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Zou</surname><given-names>Q</given-names></string-name>, et al</person-group>. <article-title>The composition and roles of gastric stem cells in epithelial homeostasis, regeneration, and tumorigenesis</article-title>. <source>Cell Oncol</source>. <year>2023</year>;<volume>46</volume>(<issue>4</issue>):<fpage>867</fpage>&#8211;<lpage>883</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s13402-023-00802-z</pub-id><pub-id pub-id-type="pmid">37010700</pub-id></mixed-citation></ref><ref id="cit0010"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sbrana</surname><given-names>FV</given-names></string-name>, <string-name name-style="western"><surname>Cortini</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Avnet</surname><given-names>S</given-names></string-name>, et al</person-group>. <article-title>The role of autophagy in the maintenance of stemness and differentiation of mesenchymal stem cells</article-title>. <source>STEM Cell Rev And Rep</source>. <year>2016</year>;<volume>12</volume>(<issue>6</issue>):<fpage>621</fpage>&#8211;<lpage>633</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12015-016-9690-4</pub-id><pub-id pub-id-type="pmid">27696271</pub-id></mixed-citation></ref><ref id="cit0011"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Courtois</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Haykal</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Bodineau</surname><given-names>C</given-names></string-name>, et al</person-group>. <article-title>Autophagy induced by <italic toggle="yes">Helicobacter pylori</italic> infection is necessary for gastric cancer stem cell emergence</article-title>. <source>Gastric Cancer</source>. <year>2021</year>;<volume>24</volume>(<issue>1</issue>):<fpage>133</fpage>&#8211;<lpage>144</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10120-020-01118-9</pub-id><pub-id pub-id-type="pmid">32940810</pub-id></mixed-citation></ref><ref id="cit0012"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ding</surname><given-names>SZ</given-names></string-name>, <string-name name-style="western"><surname>Zheng</surname><given-names>PY</given-names></string-name></person-group>. <article-title><italic toggle="yes">Helicobacter pylori</italic> infection induced gastric cancer; advance in gastric stem cell research and the remaining challenges</article-title>. <source>Gut Pathog</source>. <year>2012</year>;<volume>4</volume>(<issue>1</issue>):<fpage>18</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1757-4749-4-18</pub-id><pub-id pub-id-type="pmid">23217022</pub-id><pub-id pub-id-type="pmcid">PMC3536631</pub-id></mixed-citation></ref><ref id="cit0013"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Marcucci</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Ghezzi</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Rumio</surname><given-names>C</given-names></string-name></person-group>. <article-title>The role of autophagy in the cross-talk between epithelial-mesenchymal transitioned tumor cells and cancer stem-like cells</article-title>. <source>Mol Cancer</source>. <year>2017</year>;<volume>16</volume>(<issue>3</issue>). doi: <pub-id pub-id-type="doi">10.1186/s12943-016-0573-8</pub-id><pub-id pub-id-type="pmcid">PMC5282816</pub-id><pub-id pub-id-type="pmid">28137290</pub-id></mixed-citation></ref><ref id="cit0014"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Pradella</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Naro</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Sette</surname><given-names>C</given-names></string-name>, et al</person-group>. <article-title>Emt and stemness: flexible processes tuned by alternative splicing in development and cancer progression</article-title>. <source>Mol Cancer</source>. <year>2017</year>;<volume>16</volume>(<issue>8</issue>). doi: <pub-id pub-id-type="doi">10.1186/s12943-016-0579-2</pub-id><pub-id pub-id-type="pmcid">PMC5282733</pub-id><pub-id pub-id-type="pmid">28137272</pub-id></mixed-citation></ref><ref id="cit0015"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Babaei</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>gholizadeh-Ghaleh Aziz</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Zare Zavieyh Jaghi</surname><given-names>N</given-names></string-name></person-group>. <article-title>Emt, cancer stem cells and autophagy: the three main axes of metastasis</article-title>. <source>Biomed Pharmacother</source>. <year>2021</year>;<volume>133</volume>:<fpage>110909</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biopha.2020.110909</pub-id><pub-id pub-id-type="pmid">33227701</pub-id></mixed-citation></ref><ref id="cit0016"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jason</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Cui</surname><given-names>W</given-names></string-name></person-group>. <article-title>Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination</article-title>. <source>Development</source>. <year>2016</year>;<volume>143</volume>(<issue>17</issue>):<fpage>3050</fpage>&#8211;<lpage>3060</lpage>. doi: <pub-id pub-id-type="doi">10.1242/dev.137075</pub-id><pub-id pub-id-type="pmid">27578176</pub-id></mixed-citation></ref><ref id="cit0017"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chen</surname><given-names>HT</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Mao</surname><given-names>MJ</given-names></string-name>, et al</person-group>. <article-title>Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy</article-title>. <source>Mol Cancer</source>. <year>2019</year>;<volume>18</volume>(<issue>1</issue>):<fpage>101</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12943-019-1030-2</pub-id><pub-id pub-id-type="pmid">31126310</pub-id><pub-id pub-id-type="pmcid">PMC6533683</pub-id></mixed-citation></ref><ref id="cit0018"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Baker</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>ten Dijke</surname><given-names>P</given-names></string-name></person-group>. <article-title>TGF-&#946;-mediated epithelial-mesenchymal transition and cancer metastasis</article-title>. <source>Int J Mol Sci</source>. <year>2019</year>;<volume>20</volume>(<issue>11</issue>):<fpage>2767</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms20112767</pub-id><pub-id pub-id-type="pmid">31195692</pub-id><pub-id pub-id-type="pmcid">PMC6600375</pub-id></mixed-citation></ref><ref id="cit0019"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Serrano-Gomez</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Maziveyi</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Alahari</surname><given-names>SK</given-names></string-name></person-group>. <article-title>Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications</article-title>. <source>Mol Cancer</source>. <year>2016</year>;<volume>15</volume>(<issue>1</issue>):<fpage>18</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12943-016-0502-x</pub-id><pub-id pub-id-type="pmid">26905733</pub-id><pub-id pub-id-type="pmcid">PMC4765192</pub-id></mixed-citation></ref><ref id="cit0020"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wang</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Guo</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Jia</surname><given-names>J</given-names></string-name>, et al</person-group>. <article-title>Silencing TAB182 inhibits cell EMT, migration and invasion by downregulating EGFR in A549 NSCLC cells</article-title>. <source>Mol Biol Rep</source>. <year>2023</year>;<volume>50</volume>(<issue>4</issue>):<fpage>3073</fpage>&#8211;<lpage>3083</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11033-022-08176-5</pub-id><pub-id pub-id-type="pmid">36689051</pub-id></mixed-citation></ref><ref id="cit0021"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rossi</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Manfrin</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Lutolf</surname><given-names>MP</given-names></string-name></person-group>. <article-title>Progress and potential in organoid research</article-title>. <source>Nat Rev Genet</source>. <year>2018</year>;<volume>19</volume>(<issue>11</issue>):<fpage>671</fpage>&#8211;<lpage>687</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41576-018-0051-9</pub-id><pub-id pub-id-type="pmid">30228295</pub-id></mixed-citation></ref><ref id="cit0022"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sato</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Vries</surname><given-names>RG</given-names></string-name>, <string-name name-style="western"><surname>Snippert</surname><given-names>HJ</given-names></string-name>, et al</person-group>. <article-title>Single <italic toggle="yes">lgr5</italic> stem cells build crypt-villus structures in vitro without a mesenchymal niche</article-title>. <source>Nature</source>. <year>2009</year>;<volume>459</volume>(<issue>7244</issue>):<fpage>262</fpage>&#8211;<lpage>265</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature07935</pub-id><pub-id pub-id-type="pmid">19329995</pub-id></mixed-citation></ref><ref id="cit0023"><label>[23]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Clevers</surname><given-names>H</given-names></string-name></person-group>. <article-title>Modeling development and disease with organoids</article-title>. <source>Cell</source>. <year>2016</year>;<volume>165</volume>(<issue>7</issue>):<fpage>1586</fpage>&#8211;<lpage>1597</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2016.05.082</pub-id><pub-id pub-id-type="pmid">27315476</pub-id></mixed-citation></ref><ref id="cit0024"><label>[24]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lancaster</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Knoblich</surname><given-names>JA</given-names></string-name></person-group>. <article-title>Organogenesis in a dish: modeling development and disease using organoid technologies</article-title>. <source>Science</source>. <year>2014</year>;<volume>345</volume>(<issue>6194</issue>):<fpage>1247125</fpage>. doi: <pub-id pub-id-type="doi">10.1126/science.1247125</pub-id><pub-id pub-id-type="pmid">25035496</pub-id></mixed-citation></ref><ref id="cit0025"><label>[25]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sato</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Clevers</surname><given-names>H</given-names></string-name></person-group>. <article-title>Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications</article-title>. <source>Science</source>. <year>2013</year>;<volume>340</volume>(<issue>6137</issue>):<fpage>1190</fpage>&#8211;<lpage>1194</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.1234852</pub-id><pub-id pub-id-type="pmid">23744940</pub-id></mixed-citation></ref><ref id="cit0026"><label>[26]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Burkitt</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Duckworth</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Williams</surname><given-names>JM</given-names></string-name>, et al</person-group>. <article-title><italic toggle="yes">Helicobacter pylori</italic>-induced gastric pathology: insights from in vivo and ex vivo models</article-title>. <source>Disease Model Mechanisms</source>. <year>2017</year>;<volume>10</volume>(<issue>2</issue>):<fpage>89</fpage>&#8211;<lpage>104</lpage>. doi: <pub-id pub-id-type="doi">10.1242/dmm.027649</pub-id><pub-id pub-id-type="pmcid">PMC5312008</pub-id><pub-id pub-id-type="pmid">28151409</pub-id></mixed-citation></ref><ref id="cit0027"><label>[27]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Qadri</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Rasool</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Gulzar</surname><given-names>GM</given-names></string-name>, et al</person-group>. <article-title><italic toggle="yes">H. pylori</italic> infection, inflammation and gastric cancer</article-title>. <source>J Gastrointest canc</source>. <year>2014</year>;<volume>45</volume>(<issue>2</issue>):<fpage>126</fpage>&#8211;<lpage>132</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12029-014-9583-1</pub-id><pub-id pub-id-type="pmid">24557546</pub-id></mixed-citation></ref><ref id="cit0028"><label>[28]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Diab</surname><given-names>KAS</given-names></string-name>, <string-name name-style="western"><surname>Aboul-Ela</surname><given-names>EI</given-names></string-name></person-group>. <article-title>In vivo comparative studies on antigenotoxicity of date palm (Phoenix dactylifera L.) pits extract against DNA damage induced by N-nitroso-N-methylurea in mice</article-title>. <source>Toxicol Int</source>. <year>2012</year>;<volume>19</volume>(<issue>3</issue>):<fpage>279</fpage>&#8211;<lpage>286</lpage>. doi: <pub-id pub-id-type="doi">10.4103/0971-6580.103669</pub-id><pub-id pub-id-type="pmid">23293467</pub-id><pub-id pub-id-type="pmcid">PMC3532774</pub-id></mixed-citation></ref><ref id="cit0029"><label>[29]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Li</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>He</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>R</given-names></string-name>, et al</person-group>. <article-title>Integrin-linked kinase in the development of gastric tumors induced by <italic toggle="yes">Helicobacter pylori</italic>: regulation and prevention potential</article-title>. <source>Helicobacter</source>. <year>2024</year>;<volume>29</volume>(<issue>4</issue>):<fpage>e13109</fpage>. doi: <pub-id pub-id-type="doi">10.1111/hel.13109</pub-id><pub-id pub-id-type="pmid">38951739</pub-id></mixed-citation></ref><ref id="cit0030"><label>[30]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Akbari</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Noorbakhsh Varnosfaderani</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Haeri</surname><given-names>MS</given-names></string-name>, et al</person-group>. <article-title>Autophagy induced by <italic toggle="yes">Helicobacter pylori</italic> infection can lead to gastric cancer dormancy, metastasis, and recurrence: new insights</article-title>. <source>Hum Cell</source>. <year>2024</year>;<volume>37</volume>(<issue>1</issue>):<fpage>139</fpage>&#8211;<lpage>153</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s13577-023-00996-2</pub-id><pub-id pub-id-type="pmid">37924488</pub-id></mixed-citation></ref><ref id="cit0031"><label>[31]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chu</surname><given-names>H</given-names></string-name>, et al</person-group>. <article-title><italic toggle="yes">Helicobacter pylori</italic> and autophagy: a new facet in cellular defense against bacterial infection</article-title>. <source>Autophagy</source>. <year>2010</year>;<volume>6</volume>(<issue>1</issue>):<fpage>123</fpage>&#8211;<lpage>124</lpage>.</mixed-citation></ref><ref id="cit0032"><label>[32]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Terebiznik</surname><given-names>MR</given-names></string-name>, <string-name name-style="western"><surname>Vazquez</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Torbicki</surname><given-names>K</given-names></string-name>, et al</person-group>. <article-title>Helicobacter pylori VacA toxin promotes bacterial intracellular survival in gastric epithelial cells</article-title>. <source>J Cell Biol</source>. <year>2009</year>;<volume>188</volume>(<issue>3</issue>):<fpage>425</fpage>&#8211;<lpage>436</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.01085-06</pub-id><pub-id pub-id-type="pmcid">PMC1698066</pub-id><pub-id pub-id-type="pmid">17000720</pub-id></mixed-citation></ref><ref id="cit0033"><label>[33]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zhang</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>J</given-names></string-name>, et al</person-group>. <article-title>Molecular mechanism of <italic toggle="yes">helicobacter pylori</italic>-induced autophagy in gastric cancer: a review</article-title>. <source>Oncol Lett</source>. <year>2019</year>;<volume>18</volume>(<issue>6</issue>):<fpage>6221</fpage>&#8211;<lpage>6227</lpage>. doi: <pub-id pub-id-type="doi">10.3892/ol.2019.10976</pub-id><pub-id pub-id-type="pmid">31788098</pub-id><pub-id pub-id-type="pmcid">PMC6865805</pub-id></mixed-citation></ref><ref id="cit0034"><label>[34]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zhu</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Xue</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></string-name>, et al</person-group>. <article-title><italic toggle="yes">Helicobacter pylori</italic> vacA induces autophagic cell death in gastric epithelial cells via the endoplasmic reticulum stress pathway</article-title>. <source>Cell Death Dis</source>. <year>2017</year>;<volume>8</volume>(<issue>12</issue>):<fpage>3207</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41419-017-0011-x</pub-id><pub-id pub-id-type="pmid">29238039</pub-id><pub-id pub-id-type="pmcid">PMC5870595</pub-id></mixed-citation></ref><ref id="cit0035"><label>[35]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Liao</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>C</given-names></string-name>, et al</person-group>. <article-title>LC3A-positive &#8220;stone-like&#8221; structures predict an adverse prognosis of gastric cancer</article-title>. <source>Anatomical record</source>. <year>2014</year>;<volume>297</volume>(<issue>4</issue>):<fpage>653</fpage>&#8211;<lpage>662</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ar.22895</pub-id><pub-id pub-id-type="pmcid">PMC4279981</pub-id><pub-id pub-id-type="pmid">24532538</pub-id></mixed-citation></ref><ref id="cit0036"><label>[36]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Yoshioka</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Miyata</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Doki</surname><given-names>Y</given-names></string-name>, et al</person-group>. <article-title>LC3, an autophagosome marker, is highly expressed in gastrointestinal cancers</article-title>. <source>Int J Oncol</source>. <year>2008</year>;<volume>33</volume>:<fpage>461</fpage>&#8211;<lpage>468</lpage>.<pub-id pub-id-type="pmid">18695874</pub-id></mixed-citation></ref><ref id="cit0037"><label>[37]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Amaravadi</surname><given-names>RK</given-names></string-name>, <string-name name-style="western"><surname>Kimmelman</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Debnath</surname><given-names>J</given-names></string-name></person-group>. <article-title>Targeting autophagy in cancer: recent advances and future directions</article-title>. <source>Cancer Discov</source>. <year>2019</year>;<volume>9</volume>(<issue>9</issue>):<fpage>1167</fpage>&#8211;<lpage>1181</lpage>. doi: <pub-id pub-id-type="doi">10.1158/2159-8290.CD-19-0292</pub-id><pub-id pub-id-type="pmid">31434711</pub-id><pub-id pub-id-type="pmcid">PMC7306856</pub-id></mixed-citation></ref><ref id="cit0038"><label>[38]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Huang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Hong</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Wei</surname><given-names>X</given-names></string-name></person-group>. <article-title>The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis</article-title>. <source>J Hematol Oncol</source>. <year>2022</year>;<volume>15</volume>(<issue>1</issue>):<fpage>129</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13045-022-01347-8</pub-id><pub-id pub-id-type="pmid">36076302</pub-id><pub-id pub-id-type="pmcid">PMC9461252</pub-id></mixed-citation></ref><ref id="cit0039"><label>[39]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Den Hollander</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Maddela</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Mani</surname><given-names>SA</given-names></string-name></person-group>. <article-title>Spatial and temporal relationship between epithelial&#8211;mesenchymal transition (EMT) and stem cells in cancer</article-title>. <source>Clin Chem</source>. <year>2024</year>;<volume>70</volume>(<issue>1</issue>):<fpage>190</fpage>&#8211;<lpage>205</lpage>. doi: <pub-id pub-id-type="doi">10.1093/clinchem/hvad197</pub-id><pub-id pub-id-type="pmid">38175600</pub-id><pub-id pub-id-type="pmcid">PMC11246550</pub-id></mixed-citation></ref><ref id="cit0040"><label>[40]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lambert</surname><given-names>AW</given-names></string-name>, <string-name name-style="western"><surname>Weinberg</surname><given-names>RA</given-names></string-name></person-group>. <article-title>Linking EMT programmes to normal and neoplastic epithelial stem cells</article-title>. <source>Nat Rev Cancer</source>. <year>2021</year>;<volume>21</volume>(<issue>5</issue>):<fpage>325</fpage>&#8211;<lpage>338</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41568-021-00332-6</pub-id><pub-id pub-id-type="pmid">33547455</pub-id></mixed-citation></ref><ref id="cit0041"><label>[41]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Roshan</surname><given-names>MK</given-names></string-name>, <string-name name-style="western"><surname>Soltani</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Soleimani</surname><given-names>A</given-names></string-name>, et al</person-group>. <article-title>Role of AKT and mTOR signaling pathways in the induction of epithelial-mesenchymal transition (EMT) process</article-title>. <source>Biochimie</source>. <year>2019</year>;<volume>159</volume>:<fpage>56</fpage>&#8211;<lpage>64</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biochi.2019.08.003</pub-id><pub-id pub-id-type="pmid">31401189</pub-id></mixed-citation></ref><ref id="cit0042"><label>[42]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>J</given-names></string-name></person-group>. <article-title>Trefoil factor 2 regulates proliferation and apoptosis of pancreatic cancer cells and LPS-induced normal pancreatic duct cells by &#946;-catenin pathway</article-title>. <source>Cancer Manag Res</source>, <volume>12</volume>, <fpage>10705</fpage>&#8211;<lpage>10713</lpage> (<year>2020</year>). doi: <pub-id pub-id-type="doi">10.2147/CMAR.S274578</pub-id><pub-id pub-id-type="pmid">33149677</pub-id><pub-id pub-id-type="pmcid">PMC7605628</pub-id></mixed-citation></ref><ref id="cit0043"><label>[43]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Graham</surname><given-names>DY</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Yamaoka</surname><given-names>Y</given-names></string-name></person-group>. <article-title><italic toggle="yes">Helicobacter pylori</italic> pathogenesis and stem cell modulation</article-title>. <source>Gastroenterology</source>. <year>2014</year>;<volume>147</volume>:<fpage>32</fpage>&#8211;<lpage>42</lpage>.</mixed-citation></ref><ref id="cit0044"><label>[44]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sayi</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>Z</given-names></string-name></person-group>. <article-title><italic toggle="yes">Helicobacter pylori</italic> and its effect on Wnt/&#946;-catenin signaling in gastric cancer</article-title>. <source>J Clin investigation</source>. <year>2011</year>;<volume>121</volume>:<fpage>844</fpage>&#8211;<lpage>853</lpage>.</mixed-citation></ref><ref id="cit0045"><label>[45]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Shibata</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Takaishi</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Muthupalani</surname><given-names>S</given-names></string-name></person-group>. <article-title>Genotoxic stress in NMU-induced gastric changes</article-title>. <source>Cancer Res</source>. <year>2016</year>;<volume>76</volume>:<fpage>3531</fpage>&#8211;<lpage>3542</lpage>.27197154
</mixed-citation></ref><ref id="cit0046"><label>[46]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wroblewski</surname><given-names>LE</given-names></string-name>, <string-name name-style="western"><surname>Peek</surname><given-names>RM</given-names></string-name>, <string-name name-style="western"><surname>Wilson</surname><given-names>KT</given-names></string-name></person-group>. <article-title><italic toggle="yes">Helicobacter pylori</italic> and epithelial-mesenchymal signaling in gastric carcinogenesis</article-title>. <source>Gastroenterology</source>. <year>2010</year>;<volume>138</volume>:<fpage>819</fpage>&#8211;<lpage>831</lpage>.</mixed-citation></ref><ref id="cit0047"><label>[47]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Deretic</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Saitoh</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Akira</surname><given-names>S</given-names></string-name></person-group>. <article-title>Autophagy in infection, inflammation, and immunity</article-title>. <source>Nat Rev Immunol</source>. <year>2013</year>;<volume>13</volume>(<issue>10</issue>):<fpage>722</fpage>&#8211;<lpage>737</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nri3532</pub-id><pub-id pub-id-type="pmid">24064518</pub-id><pub-id pub-id-type="pmcid">PMC5340150</pub-id></mixed-citation></ref><ref id="cit0048"><label>[48]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Xu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Eom</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Nam</surname><given-names>S</given-names></string-name></person-group>. <article-title>Role of autophagy inhibition in stem cell signaling</article-title>. <source>Cell Rep</source>. <year>2019</year>;<volume>26</volume>:<fpage>1104</fpage>&#8211;<lpage>1112</lpage>.30699342
</mixed-citation></ref><ref id="cit0049"><label>[49]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Barker</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>van Es</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Kuipers</surname><given-names>J</given-names></string-name>, et al</person-group>. <article-title>Identification of stem cells in small intestine and colon by marker gene <italic toggle="yes">Lgr5</italic></article-title>. <source>Nature</source>. <year>2010</year>;<volume>449</volume>(<issue>7165</issue>):<fpage>1003</fpage>&#8211;<lpage>1007</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature06196</pub-id><pub-id pub-id-type="pmid">17934449</pub-id></mixed-citation></ref><ref id="cit0050"><label>[50]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sigal</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Rothenberg</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Logan</surname><given-names>CY</given-names></string-name>, et al</person-group>. <article-title><italic toggle="yes">Helicobacter pylori</italic> activates and expands <italic toggle="yes">Lgr5</italic>(+) stem cells through direct colonization of the gastric glands</article-title>. <source>Gastroenterology</source>. <year>2015</year>;<volume>148</volume>(<issue>7</issue>):<fpage>1392</fpage>&#8211;<lpage>1404.e21</lpage>. doi: <pub-id pub-id-type="doi">10.1053/j.gastro.2015.02.049</pub-id><pub-id pub-id-type="pmid">25725293</pub-id></mixed-citation></ref><ref id="cit0051"><label>[51]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Walter</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Sonnentag</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Munoz-Sagredo</surname><given-names>L</given-names></string-name>, et al</person-group>. <article-title>Wnt signaling is boosted during intestinal regeneration by a <italic toggle="yes">CD44</italic>-positive feedback loop</article-title>. <source>Cell Death Disease</source>. <year>2022</year>;<volume>13</volume>(<issue>2</issue>):<fpage>168</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41419-022-04607-0</pub-id><pub-id pub-id-type="pmid">35190527</pub-id><pub-id pub-id-type="pmcid">PMC8861016</pub-id></mixed-citation></ref><ref id="cit0052"><label>[52]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Misra</surname><given-names>SR</given-names></string-name>, <string-name name-style="western"><surname>Marrogi</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Cram</surname><given-names>EJ</given-names></string-name>, et al</person-group>. <article-title><italic toggle="yes">CD44</italic> and its role in gastric cancer stem cell maintenance and tumorigenesis</article-title>. <source>Clin Cancer Res</source>. <year>2015</year>;<volume>21</volume>:<fpage>3232</fpage>&#8211;<lpage>3240</lpage>.</mixed-citation></ref><ref id="cit0053"><label>[53]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Boya</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Gonz&#225;lez-Polo</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Casares</surname><given-names>N</given-names></string-name>, et al</person-group>. <article-title>Inhibition of autophagy can preserve epithelial structure by preventing apoptosis</article-title>. <source>Mol Cell Biol</source>. <year>2005</year>;<volume>25</volume>(<issue>3</issue>):<fpage>1029</fpage>&#8211;<lpage>1040</lpage>. doi: <pub-id pub-id-type="doi">10.1128/MCB.25.3.1025-1040.2005</pub-id><pub-id pub-id-type="pmcid">PMC543994</pub-id><pub-id pub-id-type="pmid">15657430</pub-id></mixed-citation></ref><ref id="cit0054"><label>[54]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Maycotte</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Jones</surname><given-names>KL</given-names></string-name>, <string-name name-style="western"><surname>Goodall</surname><given-names>ML</given-names></string-name>, et al</person-group>. <article-title>Autophagy supports breast cancer stem cell maintenance by regulating IL6 secretion</article-title>. <source>Mol Cancer Res</source>. <year>2015</year>;<volume>13</volume>(<issue>4</issue>):<fpage>651</fpage>&#8211;<lpage>658</lpage>. doi: <pub-id pub-id-type="doi">10.1158/1541-7786.MCR-14-0487</pub-id><pub-id pub-id-type="pmid">25573951</pub-id><pub-id pub-id-type="pmcid">PMC4398616</pub-id></mixed-citation></ref><ref id="cit0055"><label>[55]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Yu</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Ding</surname><given-names>K</given-names></string-name>, et al</person-group>. <article-title>Chloroquine inhibition of autophagy enhanced the anticancer effects of <italic toggle="yes">listeria monocytogenes</italic> in melanoma</article-title>. <source>Microorganisms</source>. <year>2023</year>;<volume>11</volume>(<issue>2</issue>):<fpage>408</fpage>. doi: <pub-id pub-id-type="doi">10.3390/microorganisms11020408</pub-id><pub-id pub-id-type="pmid">36838373</pub-id><pub-id pub-id-type="pmcid">PMC9958952</pub-id></mixed-citation></ref><ref id="cit0056"><label>[56]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Cocco</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Leone</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Roca</surname><given-names>MS</given-names></string-name>, et al</person-group>. <article-title>Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models</article-title>. <source>J Transl Med</source>. <year>2022</year>;<volume>20</volume>(<issue>1</issue>):<fpage>290</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12967-022-03462-z</pub-id><pub-id pub-id-type="pmid">35761360</pub-id><pub-id pub-id-type="pmcid">PMC9235112</pub-id></mixed-citation></ref><ref id="cit0057"><label>[57]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Thein</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Po</surname><given-names>WW</given-names></string-name>, <string-name name-style="western"><surname>Choi</surname><given-names>WS</given-names></string-name>, et al</person-group>. <article-title>Autophagy and digestive disorders: advances in understanding and therapeutic approaches</article-title>. <source>Biomol Ther (seoul)</source>. <year>2021</year>;<volume>29</volume>(<issue>4</issue>):<fpage>353</fpage>&#8211;<lpage>364</lpage>. doi: <pub-id pub-id-type="doi">10.4062/biomolther.2021.086</pub-id><pub-id pub-id-type="pmid">34127572</pub-id><pub-id pub-id-type="pmcid">PMC8255139</pub-id></mixed-citation></ref><ref id="cit0058"><label>[58]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Yu</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Ding</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>S</given-names></string-name>, et al</person-group>. <article-title>Autophagy in cancer immunotherapy: perspective on immune evasion and cell death interactions</article-title>. <source>Cancer Lett</source>. <year>2024</year>;<volume>590</volume>:<fpage>216856</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.canlet.2024.216856</pub-id><pub-id pub-id-type="pmid">38583651</pub-id></mixed-citation></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>